penicillanic acid has been researched along with Bacterial Disease in 256 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 84 (32.81) | 18.7374 |
| 1990's | 54 (21.09) | 18.2507 |
| 2000's | 62 (24.22) | 29.6817 |
| 2010's | 56 (21.88) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rademacher, J; Welte, T | 1 |
| Carlier, M; De Cock, PAJG; de Jaeger, A; De Paepe, P; Delanghe, JR; Della Pasqua, OE; Robays, H; van Dijkman, SC; Vande Walle, J; Verstraete, AG; Willems, J | 1 |
| Huntington, JA; Long, J; Popejoy, MW | 1 |
| Chan, JD; Dellit, TH; Lynch, JB | 1 |
| Hahn, U; Lipman, J; Peake, SL; Roberts, JA; Roberts, MS; Sime, FB; Tiong, IS; Warner, MS | 1 |
| Hatti, M; Odenholt, I; Resman, F; Solomonidi, N; Tham, J | 1 |
| Ashhurst-Smith, C; Ferguson, JK; Hughes, C | 1 |
| Hao, D; Hu, Z; Liu, X; Sun, T; Tian, H; Wang, T; Wang, X | 1 |
| Cabri, W; Cerisoli, L; Ferrazzano, L; Martelli, G; Ricci, A; Tolomelli, A; Viola, A | 1 |
| Falagas, ME; Ikawa, K; Tansarli, GS; Vardakas, KZ | 2 |
| Gupta, N; Rodrigues, C; Shetty, A; Soman, R | 1 |
| Damas, P; Frippiat, F; Lambermont, B; Vercheval, C | 1 |
| Charoenpong, L; Thamlikitkul, V; Tongsai, S | 1 |
| Chhibba, A; Nayak, U; Patankar, M; Sequeira, L; Sukumaran, S | 1 |
| Leung, E; Ly, SC; Scheetz, MH; Venkatesan, N | 1 |
| Bandettini, R; Buffa, P; Castagnola, E; Caviglia, I; Ciucci, A; Ginocchio, F; Guida, E; Haupt, R; Loy, A; Masa, DL; Mattioli, G; Perotti, M; Pini Prato, A | 1 |
| Cies, JJ; Kuti, JL; Schlichting, C; Shankar, V | 1 |
| Boral, OB; Cağatay, P; Keçeli, SA; Sonmez, N; Tamer, GS; Willke, A | 1 |
| Arisoy, ES; Corapcioglu, F; Demirsoy, U; Karadogan, M; Karakurt, DG; Oncel, S | 1 |
| Jain, N; Tewari, VV | 1 |
| Han, S; Hong, T; Jeon, S; Lee, J; Paek, J; Woo, H; Yim, DS | 1 |
| Attivi, D; Gibaud, S | 1 |
| Boselli, E; Felton, TW; Hope, WW; Lodise, TP; Neely, MN; Roberts, JA; Van Guilder, M | 1 |
| Chandorkar, G; Hershberger, E; Krishna, G; Mouksassi, MS; Xiao, A | 1 |
| Kishimoto, K; Kobayashi, K; Kobayashi, R; Sano, H; Suzuki, D; Yasuda, K | 1 |
| Chmura, A; Durlik, M; Kawecki, D; Lagiewska, B; Mlynarczyk, G; Pacholczyk, M; Sawicka-Grzelak, A | 1 |
| Agudelo, M; Rodriguez, CA; Vesga, O; Zuluaga, AF | 1 |
| Chen, L; Wang, Y; Yang, H; Zhang, C; Zhou, Q | 1 |
| Barie, PS; Collins, S; Eckmann, C; Friedland, I; Hershberger, E; Miller, B; Popejoy, M; Solomkin, J; Steenbergen, J; Yoon, M; Yuan, G | 1 |
| Pineda, LC; Watt, KM | 1 |
| Bhattacharya, S; Bhaumik, J; Chandy, M; Goel, G; Mukherjee, S | 1 |
| Davies, SW; Dietch, ZC; Efird, JT; Guidry, CA; Sawyer, RG; Shah, PM; Willis, RN | 1 |
| Brass, EP; Spellberg, B | 1 |
| Eckmann, C; Hershberger, E; Solomkin, JS | 1 |
| Aamir, M; Abrol, P; Punia, H; Sharma, D | 1 |
| Gan, WJ; Mu, SM; Ran, XW; Shen, JF; Wang, J; Xian, Y; Xu, ZR; Yan, XD; Yuan, GY; Zhang, BS | 1 |
| Aduroja, OA; Amde, M; Connor, MJ; Fissell, WH; Gould, ER; Groszek, JJ; Madonia, PN; Nesbitt, R; Salem, C; Shotwell, MS; Taylor, ME; Tolwani, AJ; Wei, P | 1 |
| Foster, CB; Goldfarb, J; Gonzalez, BE; Sabella, C; Saracusa, C; Worley, S; Yusef, D | 1 |
| Connor, KA | 1 |
| Gong, R; Huang, X; Li, C; Liu, J; Liu, Y; Xu, H | 1 |
| Bassi, C; Benini, A; Bertazzoni Minelli, E; Franco, L; Pederzoli, P | 1 |
| Esposito, S; Felaco, FM; Fiore, M; Ianniello, F; Leone, S; Noviello, S; Romagnoli, F; Sarli, E | 1 |
| Bleeker-Rovers, CP; Koopman, M; Mannaerts, L; Punt, CJ; van Herpen, CM | 1 |
| Hashimoto, Y; Uji, T | 1 |
| Erdem, E; Gulec, SG; Kebudi, R; Vural, S; Yildirmak, Y | 1 |
| Bayram, H; Dalay, C; Dalkiran, A; Saltoglu, N; Sert, M; Tasova, Y; Tetiker, T | 1 |
| Carmeli, Y; Jansen, JP; Kumar, R | 1 |
| An, MM; Chen, ML; Jiang, YY; Liu, P; Shen, H; Wang, R; Zhang, JD; Zou, Z | 1 |
| Blondiaux, N; Courcol, RJ; Durocher, A; Favory, R; Nseir, S; Onimus, T; Roussel-Delvallez, M; Wallet, F | 1 |
| Akduman, D; Ankarali, H; Aydemir, H; Celebi, G; Engin, H; Gokmen, A; Keskin, AS; Oztoprak, N; Piskin, N | 1 |
| Hayashi, Y; Lipman, J; Paterson, DL; Roberts, JA | 1 |
| Bansal, D; Gautam, V; Marwaha, N; Marwaha, RK; Oberoi, S; Sharma, RR | 1 |
| Ariga, T; Cho, Y; Ichikawa, M; Iguchi, A; Kaneda, M; Ohshima, J; Suzuki, D | 1 |
| Arakawa, S; Fujisawa, M; Matsumoto, T; Miura, T; Nakano, Y; Shigemura, K; Takahashi, S; Tanaka, K; Tsukamoto, T | 1 |
| Deman, H; Spriet, I; Verhaegen, J; Willems, L | 1 |
| Dwivedi, A; Gupta, SK; Pratyush, DD; Rai, M; Singh, SK; Tiwari, S | 1 |
| Farbman, L; Gafter-Gvili, A; Leibovici, L; Paul, M; Peck, A; Raanani, P; Ram, R; Shpilberg, O; Vidal, L; Yeshurun, M | 1 |
| Holzgrabe, U | 1 |
| Beumier, M; Cotton, F; De Backer, D; Hites, M; Jacobs, F; Lorent, S; Roisin, S; Seyler, L; Surin, R; Taccone, FS; Vincent, JL; Wolff, F | 1 |
| Alder, J; Arvis, P; Dryden, M; Gyssens, IC; Kujath, P; Nathwani, D; Reimnitz, P; Schaper, NC | 1 |
| Berardi, B; Callea, A; Cormio, L; Fiorentino, N; Sblendorio, D; Traficante, A; Zizzi, V | 1 |
| Bornhauser, M; Ehninger, G; Hanel, M; Kroschinsky, F; Ordemann, R; Schuler, U; Wichmann, G | 1 |
| Friedland, I; Majumdar, A; Mixson, LA; Motyl, M; Woods, GL | 1 |
| Powell, LL; Wilson, SE | 1 |
| Gesser, R; McCarroll, K; Tellado, J; Teppler, H; Woods, GL | 1 |
| Esposito, S; Ianniello, F; Leone, S; Maiello, A; Marvaso, A; Noviello, S; Petronella, P | 1 |
| Charlett, A; Henwood, CJ; James, D; Johnson, AP; Livermore, DM; Mushtaq, S; Potz, N; Walker, RA; Warburton, F; Warner, M | 1 |
| Burroughs, A; Fisher, N; Hastings, M; Kibbler, C; Mutimer, D; O'Grady, J; Patch, D; Philpott-Howard, J; Rolando, N; Wade, J; Wendon, J | 1 |
| Bethe, U; Breuer, K; Cornely, OA; Diehl, V; Fätkenheuer, G; Karthaus, M; Reichert, D; Salzberger, B; Schwonzen, M; Seifert, H; Ullmann, AJ; Wicke, T | 1 |
| Meibohm, AR; Teppler, H; Woods, GL | 1 |
| Kwan, TH; Siu, YP; Tong, MK; Yung, CY | 1 |
| Gesser, RM; Graham, DR; Meibohm, AR; Roy, S; Solomkin, J; Teppler, H; Woods, GL | 1 |
| Friedland, IR; Gesser, RM; Herman, G; Isaacs, R; Meibohm, A; Mistry, G; Teppler, H; Woods, GL | 1 |
| Boghossian, J; Caputo, W; Dana, A; Gray, S; Harkless, L; Pollak, R; Wu, D | 1 |
| Dzierzanowska, D; Dzierzanowska-Fangrat, K; Kurlenda, J; Małafiej, E; Puacz, E; Semczuk, K; Stalmaska-Dworak, E; Łopaciuk, U | 1 |
| Farga, A; Faus, F; Gimeno, C; Gómez, C; Goterris, R; Gutierrez, A; Martinez, F; Muñoz, I; Navarro, D; Solano, C | 1 |
| Bordigoni, P; Chastagner, P; Fouyssac, F; Mansuy, L; Salmon, A; Schmitt, C | 1 |
| Dana, A; Kuti, JL; Li, C; Mansfield, DL; Nicolau, DP; Nightingale, CH | 1 |
| Almassi, GH; Brown, KR; Edmiston, CE; Kehl, KS; Krepel, CJ; Lewis, BD; Loehrl, TA; Seabrook, GR; Smith, TL; Somberg, LB; Towne, JB | 1 |
| Jacobus, NV; Kuck, NA; Petersen, PJ; Tally, FP; Testa, RT; Weiss, WJ | 1 |
| Kuti, JL; Nicolau, DP; Ong, CT | 1 |
| Dana, A; DeRyke, CA; Kuti, JL; Mansfield, D; Nicolau, DP | 1 |
| Bhattacharya, SK; Kumari, N; Mohapatra, TM; Rai, A | 1 |
| Asperger, W; Chan, CY; Dela Pena, AS; DiNubile, MJ; Giezek, H; Kafka, R; Köckerling, F; Raz, R; Shivaprakash, M; Vrijens, F; Warren, B | 1 |
| Aslanzadeh, J; Brecher, S; Brossette, SE; Gavin, PJ; Gaydos, JM; Halstead, DC; Peterson, LR; Pierson, CL; Rotstein, C; Suseno, MT; Thomson, RB | 1 |
| Choudhri, S; Herrington, J; Malangoni, MA; Pertel, P; Song, J | 1 |
| Dana, A; Itani, KM; Kuti, JL; Lau, WK; Mansfield, D; Mercer, D; Nicolau, DP | 1 |
| Cafiero, F; Furfaro, E; Machetti, M; Majabo, MJ; Novelli, A; Solari, N; Viscoli, C | 1 |
| Burgess, DS; Frei, CR; Hampton, SL | 1 |
| Borbone, S; Cascone, C; Mezzatesta, ML; Santagati, M; Stefani, S | 1 |
| Ammann, RA; Bode, U; Engelhart, S; Fleischhack, G; Gröger, N; Hasan, C; Kramer, MH; Simon, A; Wilkesmann, A; Wiszniewsky, G | 1 |
| Geddes, AM; Rolinson, GN | 1 |
| Antretter, H; Bonatti, H; Guggenbichler, JP; Ladurner, R; Laesser, R; Margreiter, R; Mark, W; Muehlmann, G; Stelzmueller, I; Tabarelli, D; Tabarelli, W; Wiesmayr, S; Zimmerhackl, LB | 1 |
| Abramson, MA; Jensen, EH; Namias, N; Solomkin, JS; Tomassini, JE | 1 |
| Abramson, MA; Armstrong, DG; Lipsky, BA; Polis, AB; Sheehan, P; Tice, AD | 1 |
| Hawkey, PM; Hsueh, PR | 1 |
| Abramson, MA; Hoey, CT; Lipsky, BA; Tice, AD; Turpin, RS; Wu, J | 1 |
| Cross, SE; Dalley, AJ; Lipman, J; Roberts, MS; Rudd, M; Venkatesh, B | 1 |
| Choudhri, S; Giordano, P; Lipsky, BA; Song, J | 1 |
| Bode, U; Fleischhack, G; Groll, AH; Laws, HJ; Lehrnbecher, T; Molitor, E; Simon, A; Tramsen, L; Wieland, R | 1 |
| Hamidah, A; Jamal, R; Nordiah, AJ; Rizal, AM | 1 |
| Aytac, S; Cengiz, AB; Cetin, M; Ceyhan, M; Secmeer, G; Tuncer, M; Yetgin, S; Yildirim, I | 1 |
| Farrar, WE | 1 |
| Aoyama, R; Asuka, N; Izumi, Y; Ohnishi, A; Waga, S | 1 |
| Honjo, T; Watanabe, A | 1 |
| Himi, K; Kurosaki, T; Matsumura, C; Nakamura, A; Sugaya, N; Suzuki, H; Terashima, I; Uehara, S | 1 |
| Hirosawa, H; Hoshina, H; Ichihashi, H; Mikuni, K | 1 |
| Arimasu, O; Fujii, R; Mashiko, J; Meguro, H; Nonaka, C; Tajima, T | 1 |
| Akita, H; Hayano, S; Iwasaki, Y; Iwata, S; Kojima, Y; Oikawa, T; Osano, M; Sato, Y; Sunakawa, K; Wakabayashi, R | 1 |
| Hakamada, S; Hayakawa, F; Kuno, K; Miyachi, Y; Nakashima, T; Ueda, S | 1 |
| Iwai, N; Katayama, M; Mizoguchi, F; Shibata, M; Taneda, Y | 1 |
| Nishimura, T; Tabuki, K; Takagi, M; Takashima, T | 1 |
| Haruta, T; Kobayashi, Y; Kuroki, S; Ohkura, K | 1 |
| Fujimoto, T; Ishimoto, K; Koga, T; Motohiro, T; Nishiyama, T; Sakata, Y; Shimada, Y; Tanaka, K; Tominaga, K; Tomita, N | 1 |
| Maki, M; Saito, Y; Tachizaki, T | 1 |
| Domon, H; Eto, M; Kodama, M; Sato, H; Shimizu, T; Washizuka, N | 1 |
| Chimura, T; Inoue, K; Morisaki, N | 1 |
| Hirai, S; Iida, S; Kohara, T; Matsui, Y; Noda, M | 1 |
| Cho, N; Fukunaga, K; Kunii, K; Moriyama, S; Takeda, H; Tsukamoto, A; Watanabe, H; Yoshida, K | 1 |
| Shitano, T; Tateno, M | 1 |
| Asamoto, A; Hoshiba, T; Yabuki, Y | 1 |
| Fukuda, O; Inoue, S; Maeyama, M; Shimokawa, K | 1 |
| Wishart, DF | 1 |
| Chikaoka, H; Nakazawa, S; Narita, A; Sato, H; Suzuki, H; Tazoe, K | 1 |
| Arai, K; Hogaki, M; Ikegawa, A; Seto, H | 1 |
| Hayasaki, M; Ito, K; Kondo, H; Noda, K | 1 |
| Ichijo, M; Kosakai, H; Moriyama, I; Shintani, M; Takayama, T | 1 |
| Horii, T; Noda, K | 1 |
| Hirabayashi, K; Okada, E | 1 |
| Kubota, K | 1 |
| Kanao, M; Okada, H; Yamamoto, T; Yasuda, J | 1 |
| Doko, F | 1 |
| Ikushima, Y; Kobayashi, H; Matsumoto, S; Shirakawa, K | 1 |
| Arimasu, O; Fujii, R; Honjo, T; Mashiko, J; Meguro, H; Nagamatsu, I; Nonaka, C; Sato, Y; Tajima, T; Watanabe, A | 1 |
| Hori, M; Kurosu, Y; Nakamura, H; Sugita, M; Takahashi, T; Toyonaga, Y | 1 |
| Hachiya, S; Imagawa, N; Koike, K; Morimoto, O; Obata, I; Ochiai, K; Ryu, F | 1 |
| Kager, L; Liljeqvist, L; Malmborg, AS; Nord, CE; Pieper, R | 1 |
| Melby, K; Rollag, H | 1 |
| Rahman, M | 1 |
| Hino, Y; Hosoda, M; Ijichi, H; Kimura, I; Kizu, A; Maeda, M; Minaga, T; Miyake, M; Mochizuki, S; Nakamura, K; Sawada, K; Yasumi, M; Yoneda, S; Yoshikawa, H | 1 |
| Frimodt-Møller, C; Vejlsgaard, R | 1 |
| Kondo, M; Tsuchiya, K | 1 |
| Otsuki, M | 1 |
| Plouffe, JF | 1 |
| Brumfitt, W; Hamilton-Miller, JM | 1 |
| Bailey, RR; Bishop, V; Blake, E; Chambers, PF; Crofts, HG; Davies, PR; Peddie, B | 1 |
| Kowalewska, E; Lipnicki, D; Osowiecki, H; Zawisza-Zenkteler, W | 1 |
| Angehrn, P; Arisawa, M | 1 |
| File, TM; Tan, JS | 3 |
| Bodey, GP; Estey, EH; Lawson, RD | 1 |
| de Louvois, J; Mulhall, A | 1 |
| Kusmiesz, H; Nelson, JD; Shelton, S | 1 |
| Cleeland, R; Squires, E | 1 |
| Gordin, FM; Sande, MA | 1 |
| Demos, CH; Green, E | 1 |
| Beam, TR; King, JW; Neu, HC; Smith, LG | 1 |
| Bauer, CA; Iosif, CS; Laurin, J; Möller, EB | 1 |
| Kager, L; Malmborg, AS; Nord, CE; Sjöstedt, S | 1 |
| Davies, BI; Maesen, FP; van Noord, JA | 1 |
| Brogden, RN; Bryson, HM | 1 |
| Aldridge, KE | 1 |
| Kinzig, M; Sörgel, F | 1 |
| Lahnborg, G; Nord, CE | 1 |
| Grundel, E; Vestweber, KH | 1 |
| Brewster, SF; Gingell, JC; MacGowan, AP | 1 |
| Liu, CY; Lui, WY; Shyr, YM; Su, CH; Wang, LS | 1 |
| Dudley, MN | 1 |
| Jones, RN | 1 |
| Danziger, LH; Occhipinti, DJ; Rodvold, KA; Schoonover, LL | 1 |
| Fujii, R; Fujita, K; Fukushima, N; Inyaku, F; Ishikawa, A; Okuno, A; Saijo, M; Takimoto, M; Wagatsuma, S; Yoshikawa, M | 1 |
| Gorbach, SL | 1 |
| Nord, CE | 1 |
| Nowé, P | 1 |
| Bywater, MJ; Holt, HA; MacGowan, AP; Reeves, DS | 1 |
| Faro, S; O'Brien, WF; Roy, S; Sanfilippo, JS; Seidlin, M; Sweet, RL | 1 |
| Alhava, E; Haapiainen, R; Havia, T; Kivilaakso, E; Laitinen, S; Matikainen, M; Miettinen, P; Niinikoski, J; Pääkkönen, M | 1 |
| Cullmann, W; Elhardt, D; Tassler, H | 1 |
| Acar, JF; Goldstein, FW; Kitzis, MD | 1 |
| DeVries, VG; Kuye, O; Morrow, CA; Tally, FP; Teal, J | 1 |
| Eklund, AE; Nord, CE | 1 |
| Gentile, G; Girmenia, C; Martino, P; Meloni, G; Micozzi, A; Nucci, M; Venditti, M | 1 |
| Gupte, JM; Immermann, FW; Jacobus, NV; Testa, RT | 1 |
| Barie, PS; Cheadle, WG; Fink, MP; Garber, GE; Hebert, JC; Laverdiere, M; Polk, HC; Wilson, SE | 1 |
| Bourget, P; Carsin, H; Le Bever, H; Le Reveillé, R; Lesne-Hulin, A | 1 |
| Blumer, JL; Bonafede, ME | 1 |
| Chimura, T; Hirayama, T | 1 |
| Dvoretskiĭ, LI; Eremina, LV; Iakovlev, SV; Kaĭnov, MS; Koroleva, TA; Orlova, EA; Romanovskiĭ, IuIa; Shakhova, TV; Zhulin, SL | 1 |
| Iakovlev, SV | 1 |
| Chernen'kaia, TV; Lobakov, AI; Nasonov, VN; Rusanova, EV; Savitskaia, KI; Savov, AM; Silkina, TA | 1 |
| Higashitani, F; Hyodo, A; Kunugita, C; Nishida, K; Unemi, N | 1 |
| Dudley, MN; Okereke, C | 1 |
| Asuka, T; Chiba, C; Kitazawa, J; Okamoto, T; Saito, T; Sato, Y; Takahashi, Y; Tateyama, N; Tsushima, T; Waga, S; Yokoyama, M | 1 |
| Ishihara, T; Nakamura, H; Tezuka, T; Toyonaga, Y | 1 |
| Iwai, N; Miyazu, M; Nakamura, H | 1 |
| Hayakawa, F; Itomi, K; Kato, T; Kuno, K; Miyajima, Y; Ogawa, A; Okumura, A; Takahashi, H | 1 |
| Ihara, T; Kamiya, H; Kitamura, K; Nishimori, H | 1 |
| Aida, K; Aramaki, M; Fukuda, T; Hayashi, M; Hoshuyama, A; Ikezawa, S; Imai, S; Kato, H; Matsuo, Y; Morita, J; Motohiro, T; Nagai, K; Oda, K; Oki, S; Sakata, Y; Takahgashi, K; Tananari, Y; Tsumura, N; Tsutsumi, T; Yamada, T; Yamakawa, R; Yamashita, Y; Yoshinaga, Y | 1 |
| Kim, KH; Park, KW; Yim, CB | 1 |
| Bryce, EA; Frighetto, LO; Jewesson, PJ; Marra, CA; Marra, FO; Reynolds, RP; Sleigh, KM; Stiver, HG | 1 |
| Baudard, M; Bouvet, A; Chast, F; Delmer, A; Legrand, O; Levy, V; Marie, JP; Marjanovic, Z; Rio, B; Vekhoff, A; Zittoun, R | 1 |
| Caballero, D; Encinas, MP; García-Sanz, R; Gutiérrez, N; Hurlé, AD; Morín, LS; Vázquez, L; Vilches, P | 1 |
| Markham, A; Perry, CM | 1 |
| Cederberg, A; Forssell, H; Ohlin, B; Solhaug, JH; Tveit, E | 1 |
| Buchman, TG; Cheadle, WG; Cohn, SM; Haverstock, DC; Jungerwirth, S; Kowalsky, SF; Lipsett, PA; Milsom, JW; O'Marro, S; Rochefort, EV; Yellin, AE | 1 |
| Bolsoni, AP; Mendes, RE; Roland, RK; Sader, HS; Silbert, S | 1 |
| Christou, N; Eiseman, I; Siami, G; Tack, KJ | 1 |
| Daschner, F; Dietrich, ES; Ebner, W; Schubert, B | 1 |
| Niki, Y | 1 |
| Hidai, H | 1 |
| Mealey, KL | 1 |
| Bode, U; Fleischhack, G; Hasan, C; Havers, W; Marklein, G; Schmidt-Niemann, M; Wulff, B | 1 |
| Bucaneve, G; D'Antonio, D; Del Favero, A; Furno, P; Gentile, G; Mandelli, F; Martino, B; Martino, P; Menichetti, F; Micozzi, A; Ricci, P; Russo, D | 1 |
| Dubau, B; Frappier, S; Hernandez, V; Pédeboscq, S; Pometan, JP; Veyssières, D; Winnock, S | 1 |
| Androulakakis, E; Dimitriou, L; Kafetzis, DA; Lebesii, E; Maltezou, HC; Nikolaidis, P | 1 |
| Plosker, GL; Young, M | 1 |
| Liu, Y; Wang, R; Yu, B | 1 |
| Grant, EM; Kuti, JL; Nicolau, DP; Nightingale, C; Quintiliani, R | 1 |
| Asper, R; Schwartz, AR | 1 |
| Beskid, G; Cleeland, R; DeLorenzo, WF; Grunberg, E | 1 |
| Gray, J | 1 |
| Abraham, EP | 1 |
| Jensen, G | 1 |
| Marsh, BT; Menday, AP | 1 |
| Bodey, GP; Rodriguez, V; Weaver, S | 1 |
| Ingold, A | 1 |
| Spencer, RC; Wilcox, MH; Winstanley, TG | 1 |
| Brismar, B; Kasholm-Tengve, B; Nord, CE; Tunevall, G | 1 |
| Kelsey, SM; Newland, AC; Pocock, CE; Shaw, E; Weinhardt, B | 1 |
| Bäckstrand, B; Bergman, L; Brismar, B; Kihlström, E; Malmborg, AS; Mentzing, LO; Nyström, PO; Skau, T; Tunevall, G; Wretlind, B | 1 |
| Ansari, A; Douglas, JG; Gould, IM; Harvey, G; Reid, TM; Smith, CC | 1 |
| Jacobus, NV; Kuck, NA; Petersen, PJ; Testa, RT; Weiss, WJ | 1 |
| Adinolfi, MF; Galli, R; Nichols, RL; Smith, JW; Vivoda, LM | 1 |
| Conner, CS | 1 |
| Hirayama, H; Kashiwagura, T; Matsuda, S | 1 |
| Barry, AL; Jones, RN; Thornsberry, C; Wilson, HW | 1 |
| Barnett, AH; Chiodini, PL; Farrell, ID; Geddes, AM; Gilbert, J; Odugbesan, O; Toop, MJ | 1 |
| Croft, RJ; Hilas, A; Mehtar, S | 1 |
| Hunt, P; Reines, HD; Stromberg, BV | 1 |
| Eibach, HW; Koerner, H; Senft, HH; Stiglmayer, R | 1 |
| Neu, HC | 1 |
| Aronoff, SC; Jacobs, MR; Labrozzi, PH; Yamabe, S | 1 |
| Crombleholme, WR; DeKay, V; Ohm-Smith, M; Robbie, MO; Sweet, RL | 1 |
| Barba, D; Esposito, S; Galante, D; Ruffilli, MP | 1 |
| Brogden, RN; Campoli-Richards, DM | 1 |
| Christoffersen, JC; Iversen, HG; Jacobsen, J; Korner, B; Petersen, HK; Rasmussen, F; Tybring, L | 1 |
| Chain, E | 1 |
38 review(s) available for penicillanic acid and Bacterial Disease
| Article | Year |
|---|---|
[New antibiotics - standstill or progress].
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Infections; Ceftaroline; Ceftazidime; Cephalosporins; Clinical Trials as Topic; Drug Approval; Drug Combinations; Drug Resistance, Multiple, Bacterial; Ephedrine; Humans; Macrolides; Methicillin-Resistant Staphylococcus aureus; Organophosphates; Oxazoles; Penicillanic Acid; Phenobarbital; Staphylococcal Infections; Tazobactam; Theophylline; Triazoles | 2017 |
Continuous infusion of piperacillin/tazobactam in patients with severe infections: A possible pharmacokinetic optimisation?
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Drug Costs; Drug Stability; Humans; Infusions, Intravenous; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2014 |
Clinical outcomes with alternative dosing strategies for piperacillin/tazobactam: a systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Bacterial Infections; Clinical Trials as Topic; Databases, Factual; Humans; Odds Ratio; Penicillanic Acid; Piperacillin; Renal Insufficiency; Tachycardia; Tazobactam | 2015 |
New antibiotic dosing in infants.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Clindamycin; Humans; Infant; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Meropenem; Metronidazole; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Practice Guidelines as Topic; Thienamycins | 2015 |
[Pharmacological properties and clinical efficacies of tazobactam/piperacillin (Zosyn 2.25, Zosyn 4.5), an injectable antibiotic combined with beta-lactamase inhibitor].
Topics: Adult; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Child; Clinical Trials as Topic; Drug Resistance, Bacterial; Humans; Injections, Intravenous; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2009 |
Ertapenem versus piperacillin/tazobactam for the treatment of complicated infections: a meta-analysis of randomized controlled trials.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Ertapenem; Humans; Penicillanic Acid; Piperacillin; Randomized Controlled Trials as Topic; Tazobactam; Treatment Outcome | 2009 |
Pharmacokinetic evaluation of piperacillin-tazobactam.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Drug Administration Schedule; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Treatment Outcome | 2010 |
Clinical outcomes with extended or continuous versus short-term intravenous infusion of carbapenems and piperacillin/tazobactam: a systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactam Resistance; Carbapenems; Drug Administration Schedule; Humans; Infusions, Intravenous; Penicillanic Acid; Piperacillin; Tazobactam; Treatment Outcome | 2013 |
The role of beta-lactam antimicrobials as single agents in treatment of intra-abdominal infection.
Topics: Abdomen; Abdominal Abscess; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Carbapenems; Cephalosporins; Clavulanic Acids; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Surgical Wound Infection; Ticarcillin | 2000 |
Safety and tolerability of ertapenem.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Ceftriaxone; Clinical Trials as Topic; Community-Acquired Infections; Ertapenem; Female; Humans; Lactams; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Randomized Controlled Trials as Topic | 2004 |
[Treatment of febrile neutropenia episodes in children, with a piperacillin-tazobactam and netilmicin combination].
Topics: Adolescent; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Child; Child, Preschool; Clinical Trials as Topic; Drug Combinations; Drug Evaluation; Escherichia coli Infections; Female; Fever; Fever of Unknown Origin; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Infant; Male; Neoplasms; Netilmicin; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Postoperative Complications; Retrospective Studies; Treatment Outcome; Urinary Tract Infections | 2005 |
The 50th anniversary of the discovery of 6-aminopenicillanic acid (6-APA).
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cephalosporins; Humans; Hydrolysis; Penicillanic Acid; Penicillins; Thienamycins | 2007 |
Recent advances in antimicrobial drugs: the penicillins.
Topics: Animals; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactamases; Cat Diseases; Cats; Cattle; Cattle Diseases; Clavulanic Acids; Dog Diseases; Dogs; Drug Synergism; Female; Penicillanic Acid; Penicillin Resistance; Penicillins; Sulbactam | 1984 |
Amdinocillin therapy of experimental animal infections.
Topics: Amdinocillin; Animals; Anti-Bacterial Agents; Bacterial Infections; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Escherichia coli Infections; Klebsiella Infections; Klebsiella pneumoniae; Meningitis; Penicillanic Acid | 1983 |
Review of clinical experience with amdinocillin monotherapy and comparative studies.
Topics: Adolescent; Adult; Aged; Amdinocillin; Anti-Bacterial Agents; Bacterial Infections; Child; Cholecystitis; Clinical Trials as Topic; Diarrhea; Endocarditis, Bacterial; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Penicillanic Acid; Sepsis; Typhoid Fever; Urinary Tract Infections | 1983 |
Piperacillin/tazobactam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.
Topics: Animals; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Drug Combinations; Humans; Microbial Sensitivity Tests; Multicenter Studies as Topic; Penicillanic Acid; Piperacillin; Randomized Controlled Trials as Topic; Tazobactam | 1994 |
Anaerobes in polymicrobial surgical infections: incidence, pathogenicity, and antimicrobial resistance.
Topics: Abdominal Abscess; Bacteremia; Bacteria, Anaerobic; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; beta-Lactamase Inhibitors; beta-Lactamases; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Incidence; Penicillanic Acid; Peritonitis; Piperacillin; Surgical Wound Infection; Tazobactam; Virulence | 1994 |
Pharmacokinetics and tissue penetration of piperacillin/tazobactam with particular reference to its potential in abdominal and soft tissue infections.
Topics: Abdomen; Bacterial Infections; beta-Lactamase Inhibitors; Drug Therapy, Combination; Humans; Injections, Intramuscular; Injections, Intravenous; Metabolic Clearance Rate; Penicillanic Acid; Piperacillin; Soft Tissue Infections; Tazobactam; Tissue Distribution | 1994 |
Efficacy and safety of piperacillin/tazobactam in skin and soft tissue infections.
Topics: Bacterial Infections; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Necrosis; Penicillanic Acid; Piperacillin; Skin Diseases, Bacterial; Soft Tissue Infections; Tazobactam; Ticarcillin | 1994 |
Combination beta-lactam and beta-lactamase-inhibitor therapy: pharmacokinetic and pharmacodynamic considerations.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam | 1995 |
Clinical use of beta-lactamase inhibitors in combination with extended-spectrum penicillins.
Topics: Abdomen; Bacterial Infections; beta-Lactamase Inhibitors; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Respiratory Tract Infections; Soft Tissue Infections; Tazobactam | 1995 |
Piperacillin/tazobactam: a new beta-lactam/beta-lactamase inhibitor combination.
Topics: Bacterial Infections; beta-Lactamase Inhibitors; Child; Child, Preschool; Clinical Trials as Topic; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infant; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam | 1995 |
Treatment of skin and soft-tissue infections.
Topics: Bacterial Infections; beta-Lactamase Inhibitors; Drug Combinations; Fasciitis; Humans; Necrosis; Penicillanic Acid; Piperacillin; Skin Diseases; Soft Tissue Infections; Surgical Wound Infection; Tazobactam | 1995 |
Piperacillin/tazobactam in the treatment of polymicrobial infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Cephalosporins; Drug Combinations; Drug Resistance, Microbial; Humans; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam | 1994 |
The treatment of severe intra-abdominal infections: the role of piperacillin/tazobactam.
Topics: Abdomen; Bacterial Infections; beta-Lactamase Inhibitors; Clinical Trials as Topic; Drug Combinations; Humans; Penicillanic Acid; Piperacillin; Tazobactam | 1994 |
Role of newer broad-spectrum beta-lactam and fluoroquinolone antibiotics in children.
Topics: Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Carbapenems; Cephalosporins; Child; Child, Preschool; Clavulanic Acid; Clavulanic Acids; Drug Interactions; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Fluoroquinolones; Humans; Molecular Structure; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam; Ticarcillin | 1996 |
[A combined dosage form of piperacillin and tazobactam--tazocin].
Topics: Bacterial Infections; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Molecular Structure; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 1997 |
[Development of beta-lactamase inhibitors].
Topics: Animals; Bacteria; Bacterial Infections; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Drug Therapy, Combination; Mice; Penicillanic Acid; Piperacillin; Tazobactam | 1997 |
Beta-lactam/beta-lactamase inhibitor combinations: pharmacodynamic considerations and possible role in the management of bacterial infections in the neutropenic host.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactam Resistance; beta-Lactamase Inhibitors; Drug Therapy, Combination; Humans; Models, Biological; Neutropenia; Opportunistic Infections; Penicillanic Acid; Piperacillin; Tazobactam | 1998 |
Piperacillin/tazobactam: an updated review of its use in the treatment of bacterial infections.
Topics: Bacterial Infections; Clinical Trials as Topic; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam | 1999 |
[Fundamental and clinical studies on beta-lactamase inhibitors].
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Clavulanic Acid; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Penicillanic Acid; Piperacillin; Sulbactam; Tazobactam | 2001 |
[Antibiotics--TAZ/PIPC, synercid, linezolid, everninomicin].
Topics: Acetamides; Adult; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Drug Combinations; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Linezolid; Oxazolidinones; Penicillanic Acid; Penicillins; Piperacillin; Protein Synthesis Inhibitors; Tazobactam; Virginiamycin | 2001 |
Penicillins and beta-lactamase inhibitor combinations.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Clavulanic Acid; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Penicillanic Acid; Penicillins; Sulbactam; Tazobactam | 2001 |
Piperacillin/tazobactam: a pharmacoeconomic review of its use in moderate to severe bacterial infections.
Topics: Bacterial Infections; Cost-Benefit Analysis; Cross Infection; Drug Therapy, Combination; Drug Tolerance; Economics, Pharmaceutical; Hospitalization; Humans; Microbial Sensitivity Tests; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2001 |
beta-Lactam antibiotics and related substances.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Carboxypeptidases; Cephalosporinase; Cephalosporins; Drug Synergism; Humans; Hydrolases; Penicillanic Acid; Penicillin Resistance; Penicillinase; Penicillins; Staphylococcus; Streptomyces; Structure-Activity Relationship | 1977 |
The role of beta-lactamase inhibitors in chemotherapy.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Chemical Phenomena; Chemistry; Clavulanic Acid; Clavulanic Acids; Gram-Negative Bacteria; Humans; Lactams; Penicillanic Acid; Sulfones | 1985 |
Sulbactam/ampicillin. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic use.
Topics: Ampicillin; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Humans; Kinetics; Penicillanic Acid; Sulbactam | 1987 |
Thirthy years of penicillin therapy.
Topics: Animals; Autolysis; Bacterial Infections; Cephalosporins; Clostridium; Crystallography; Drug Stability; Escherichia coli; Guinea Pigs; History, 20th Century; Humans; Mice; Microbial Sensitivity Tests; Micrococcus; Muramidase; Penicillanic Acid; Penicillins; Penicillium; Rabbits; Salmonella; Streptococcal Infections | 1971 |
83 trial(s) available for penicillanic acid and Bacterial Disease
| Article | Year |
|---|---|
Analysis of patients with diabetes and complicated intra-abdominal infection or complicated urinary tract infection in phase 3 trials of ceftolozane/tazobactam.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Diabetes Complications; Diabetes Mellitus; Female; Humans; Intraabdominal Infections; Levofloxacin; Male; Metronidazole; Middle Aged; Penicillanic Acid; Pyelonephritis; Tazobactam; Urinary Tract Infections | 2017 |
Do proinflammatory cytokine levels predict serious complication risk of infection in pediatric cancer patients?
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Cytokines; Female; Fever; Humans; Infant; Inflammation Mediators; Male; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Predictive Value of Tests; Risk Factors | 2014 |
Monotherapy with amikacin or piperacillin-tazobactum empirically in neonates at risk for early-onset sepsis: a randomized controlled trial.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; India; Infant, Newborn; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Risk Factors; Sepsis; Treatment Outcome | 2014 |
Population pharmacokinetics of ceftolozane/tazobactam in healthy volunteers, subjects with varying degrees of renal function and patients with bacterial infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Female; Healthy Volunteers; Humans; Male; Middle Aged; Models, Biological; Penicillanic Acid; Renal Insufficiency; Tazobactam; Young Adult | 2015 |
Comparison between piperacillin/tazobactam and cefepime monotherapies as an empirical therapy for febrile neutropenia in children with hematological and malignant disorders: A prospective, randomized study.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Cephalosporins; Child; Child, Preschool; Febrile Neutropenia; Female; Hematologic Neoplasms; Humans; Infant; Infant, Newborn; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Young Adult | 2015 |
Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Double-Blind Method; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Intraabdominal Infections; Male; Metronidazole; Middle Aged; Penicillanic Acid; Prospective Studies; Tazobactam; Treatment Outcome; Young Adult | 2015 |
A clinical evaluation of efficacy and safety of cefepime monotherapy versus piperacillin-tazobactam in patients of paediatric age group with febrile neutropenia in a tertiary care centre of north India.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Febrile Neutropenia; Female; Fever; Humans; India; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Tertiary Care Centers; Treatment Outcome | 2016 |
Ertapenem versus piperacillin/tazobactam for diabetic foot infections in China: a Phase 3, multicentre, randomized, double-blind, active-controlled, non-inferiority trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactams; China; Diabetic Foot; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Ertapenem; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Treatment Outcome; Young Adult | 2016 |
Imipenem-cilastatin versus piperacillin-tazobactam as monotherapy in febrile neutropenia.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Fever; Humans; Imipenem; Male; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies | 2010 |
Piperacillin/tazobactam versus imipenem/cilastatin for severe diabetic foot infections: a prospective, randomized clinical trial in a university hospital.
Topics: Adult; Aged; Aged, 80 and over; Amputation, Surgical; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Diabetic Foot; Drug Combinations; Female; Hospitals, University; Humans; Imipenem; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Recurrence; Time Factors; Treatment Outcome | 2010 |
Piperacillin-tazobactam versus carbapenem therapy with and without amikacin as empirical treatment of febrile neutropenia in cancer patients: results of an open randomized trial at a university hospital.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Carbapenems; Drug Eruptions; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Survival Rate; Young Adult | 2010 |
Piperacillin/tazobactam versus cefozopran for the empirical treatment of pediatric cancer patients with febrile neutropenia.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Cefozopran; Cephalosporins; Child; Child, Preschool; Female; Fever; Humans; Male; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2011 |
Efficacy and safety of IV/PO moxifloxacin and IV piperacillin/tazobactam followed by PO amoxicillin/clavulanic acid in the treatment of diabetic foot infections: results of the RELIEF study.
Topics: Administration, Intravenous; Administration, Oral; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Aza Compounds; Bacteria; Bacterial Infections; Diabetic Foot; Female; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Penicillanic Acid; Piperacillin; Quinolines; Tazobactam; Treatment Outcome | 2013 |
Antimicrobial prophylaxis for transrectal prostatic biopsy: a prospective study of ciprofloxacin vs piperacillin/tazobactam.
Topics: Anti-Infective Agents; Antibiotic Prophylaxis; Bacterial Infections; Biopsy; Ciprofloxacin; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Injections, Intramuscular; Male; Penicillanic Acid; Penicillins; Piperacillin; Postoperative Complications; Prospective Studies; Prostatic Diseases; Tazobactam; Transurethral Resection of Prostate | 2002 |
Ertapenem versus piperacillin-tazobactam for treatment of mixed anaerobic complicated intra-abdominal, complicated skin and skin structure, and acute pelvic infections.
Topics: Abdomen; Adult; Aged; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Ertapenem; Female; Humans; Lactams; Male; Middle Aged; Pelvic Infection; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Skin Diseases, Bacterial; Surgical Wound Infection | 2002 |
Piperacillin-tazobactam versus ciprofloxacin plus amoxicillin in the treatment of infective episodes after liver transplantation.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Double-Blind Method; Drug Therapy, Combination; Enterobacteriaceae; Female; Fever; Humans; Liver Transplantation; Male; Metronidazole; Middle Aged; Penicillanic Acid; Penicillins; Piperacillin; Piperacillin, Tazobactam Drug Combination; Postoperative Complications; Prospective Studies; Staphylococcus aureus | 2003 |
Once-daily oral levofloxacin monotherapy versus piperacillin/tazobactam three times a day: a randomized controlled multicenter trial in patients with febrile neutropenia.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Bacterial Infections; Disease Susceptibility; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever; Fever of Unknown Origin; Humans; Immunocompromised Host; Levofloxacin; Male; Middle Aged; Neoplasms; Neutropenia; Ofloxacin; Penicillanic Acid; Piperacillin; Prospective Studies; Safety; Tazobactam; Treatment Outcome | 2004 |
Management of complicated appendicitis and comparison of outcome with other primary sites of intra-abdominal infection: results of a trial comparing ertapenem and piperacillin-tazobactam.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Appendicitis; Bacterial Infections; beta-Lactams; Colonic Diseases; Demography; Double-Blind Method; Ertapenem; Female; Humans; Lactams; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Risk Factors; Severity of Illness Index | 2004 |
Treatment of polymicrobial infections: post hoc analysis of three trials comparing ertapenem and piperacillin-tazobactam.
Topics: Abdomen; Adolescent; Adult; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Double-Blind Method; Ertapenem; Female; Humans; Lactams; Male; Pelvic Infection; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Skin Diseases, Bacterial; Treatment Outcome | 2004 |
An open-label, randomized study comparing efficacy and safety of intravenous piperacillin/tazobactam and ampicillin/sulbactam for infected diabetic foot ulcers.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Diabetic Foot; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Sulbactam; Time Factors; Vancomycin; Wound Infection | 2005 |
Prophylaxis of early bacterial infections after autologous peripheral blood stem cell transplantation (PBSCT): a matched-pair study comparing oral fluoroquinolones and intravenous piperacillin-tazobactam.
Topics: Adolescent; Adult; Aged; Amphotericin B; Bacteremia; Bacterial Infections; Female; Fever; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Matched-Pair Analysis; Middle Aged; Neutropenia; Penicillanic Acid; Peripheral Blood Stem Cell Transplantation; Piperacillin; Piperacillin, Tazobactam Drug Combination; Premedication; Transplantation, Autologous | 2005 |
Population pharmacokinetics and pharmacodynamics of piperacillin/tazobactam in patients with complicated intra-abdominal infection.
Topics: Abdomen; Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Penicillanic Acid; Piperacillin; Prospective Studies; Tazobactam | 2005 |
Pharmacoeconomics of continuous versus intermittent infusion of piperacillin-tazobactam for the treatment of complicated intraabdominal infection.
Topics: Abdomen; Adult; Bacterial Infections; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Penicillanic Acid; Piperacillin; Tazobactam | 2006 |
Efficacy and safety of ertapenem versus piperacillin-tazobactam for the treatment of intra-abdominal infections requiring surgical intervention.
Topics: Abdomen; Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Alanine Transaminase; Anti-Bacterial Agents; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; beta-Lactams; Diarrhea; Ertapenem; Escherichia coli Infections; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Treatment Outcome | 2006 |
Randomized controlled trial of moxifloxacin compared with piperacillin-tazobactam and amoxicillin-clavulanate for the treatment of complicated intra-abdominal infections.
Topics: Abdominal Abscess; Administration, Oral; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Appendicitis; Aza Compounds; Bacterial Infections; Cross Infection; Double-Blind Method; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Intestinal Perforation; Male; Middle Aged; Moxifloxacin; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Quinolines; Safety; Stomach Rupture; Treatment Outcome | 2006 |
Randomized, open-label, comparative study of piperacillin-tazobactam administered by continuous infusion versus intermittent infusion for treatment of hospitalized patients with complicated intra-abdominal infection.
Topics: Abdomen; Adolescent; Adult; Aged; APACHE; Bacterial Infections; Double-Blind Method; Drug Combinations; Enzyme Inhibitors; Female; Hospitalization; Humans; Infusions, Intravenous; Male; Middle Aged; Penicillanic Acid; Penicillins; Tazobactam | 2006 |
Randomized, multicenter, double-blind study of efficacy, safety, and tolerability of intravenous ertapenem versus piperacillin/tazobactam in treatment of complicated intra-abdominal infections in hospitalized adults.
Topics: Abdominal Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; APACHE; Bacterial Infections; Bacteroides; beta-Lactams; Double-Blind Method; Ertapenem; Escherichia coli; Female; Humans; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2007 |
Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin-tazobactam/amoxicillin-clavulanate.
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Aza Compounds; Bacterial Infections; Databases, Factual; Diabetic Foot; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Moxifloxacin; Penicillanic Acid; Piperacillin; Quinolines; Tazobactam | 2007 |
Piperacillin-tazobactam plus amikacin as an initial empirical therapy of febrile neutropenia in paediatric cancer patients.
Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Male; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2008 |
Piperacillin/tazobactam plus amikacin versus carbapenem monotherapy as empirical treatment of febrile neutropenia in childhood hematological malignancies.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Child; Child, Preschool; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Leukemia, Myeloid, Acute; Male; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2008 |
[Fundamental and clinical studies of sulbactam/cefoperazone in the pediatric field].
Topics: Adolescent; Age Factors; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Child; Child, Preschool; Clinical Trials as Topic; Drug Combinations; Drug Resistance, Microbial; Female; Humans; Infant; Male; Penicillanic Acid; Sulbactam | 1984 |
Pivmecillinam plus pivampicillin in complicated urinary tract infection. Double-blind comparison of the combination pivmecillinam/pivampicillin and pivmecillinam alone in patients with urinary tract infection.
Topics: Administration, Oral; Adult; Aged; Amdinocillin Pivoxil; Ampicillin; Anti-Infective Agents, Urinary; Bacterial Infections; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Penicillanic Acid; Pivampicillin; Urinary Tract Infections | 1981 |
Pivmecillinam in complicated urinary infections failing to respond to conventional therapy.
Topics: Adult; Amdinocillin Pivoxil; Bacterial Infections; Bacteriuria; Clinical Trials as Topic; Drug Combinations; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Penicillanic Acid; Proteus Infections; Proteus mirabilis; Recurrence; Staphylococcal Infections; Streptococcal Infections; Streptococcus agalactiae; Urinary Tract Infections | 1982 |
Single dose doxycycline, cefuroxime and pivmecillinam for treatment of bacterial cystitis.
Topics: Administration, Oral; Adult; Amdinocillin Pivoxil; Anti-Infective Agents, Urinary; Bacterial Infections; Cefuroxime; Cephalosporins; Clinical Trials as Topic; Cystitis; Doxycycline; Drug Combinations; Female; Humans; Injections, Intramuscular; Middle Aged; Penicillanic Acid; Random Allocation; Recurrence; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1982 |
A fixed combination of pivmecillinam and pivampicillin in complicated urinary tract infections. Double-blind comparison with pivmecillinam alone in hospitalized patients.
Topics: Adult; Aged; Amdinocillin Pivoxil; Ampicillin; Anti-Infective Agents, Urinary; Bacterial Infections; Double-Blind Method; Drug Therapy, Combination; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Penicillanic Acid; Pivampicillin; Pseudomonas Infections; Staphylococcal Infections; Urinary Tract Infections | 1983 |
Amdinocillin plus cefoxitin versus cefoxitin alone in therapy of mixed soft tissue infections (including diabetic foot infections).
Topics: Adult; Aged; Amdinocillin; Bacterial Infections; Cefoxitin; Connective Tissue Diseases; Diabetes Complications; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Random Allocation | 1983 |
Randomized trial of cefamandole plus amdinocillin versus cefamandole in serious pediatric infections.
Topics: Amdinocillin; Bacterial Infections; Cefamandole; Cephalosporins; Child; Child, Preschool; Clinical Trials as Topic; Drug Synergism; Drug Therapy, Combination; Humans; Infant; Microbial Sensitivity Tests; Pediatrics; Penicillanic Acid; Random Allocation | 1983 |
Review of clinical experience with amdinocillin monotherapy and comparative studies.
Topics: Adolescent; Adult; Aged; Amdinocillin; Anti-Bacterial Agents; Bacterial Infections; Child; Cholecystitis; Clinical Trials as Topic; Diarrhea; Endocarditis, Bacterial; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Penicillanic Acid; Sepsis; Typhoid Fever; Urinary Tract Infections | 1983 |
Treatment of urinary tract infections in gynecological patients. A randomized study comparing pivampicillin-pivmecillinam with trimethoprim-sulphamethoxazole.
Topics: Adolescent; Adult; Aged; Amdinocillin Pivoxil; Ampicillin; Bacterial Infections; Clinical Trials as Topic; Drug Combinations; Female; Humans; Middle Aged; Penicillanic Acid; Pivampicillin; Random Allocation; Sulfamethoxazole; Trimethoprim; Urinary Tract Infections | 1983 |
Clinical, bacteriological and pharmacokinetic results from an open trial of sultamicillin in patients with acute exacerbations of chronic bronchitis.
Topics: Adult; Aged; Ampicillin; Bacterial Infections; Bronchitis; Clinical Trials as Topic; Diarrhea; Drug Combinations; Female; Humans; Kinetics; Male; Middle Aged; Penicillanic Acid; Sputum; Sulbactam; Time Factors | 1984 |
Efficacy and safety of piperacillin/tazobactam in intra-abdominal infections.
Topics: Abdomen; Abdominal Abscess; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Drug Therapy, Combination; Europe; Follow-Up Studies; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Peritonitis; Piperacillin; Prospective Studies; Tazobactam | 1994 |
Results of the North American trial of piperacillin/tazobactam compared with clindamycin and gentamicin in the treatment of severe intra-abdominal infections. Investigators of the Piperacillin/Tazobactam Intra-abdominal Infection Study Group.
Topics: Abdomen; Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; beta-Lactamase Inhibitors; Clindamycin; Drug Therapy, Combination; Female; Gentamicins; Humans; Kidney; Kidney Function Tests; Male; Middle Aged; North America; Penicillanic Acid; Piperacillin; Tazobactam | 1994 |
Antimicrobial prophylaxis for transrectal prostatic biopsy: a prospective randomized trial of cefuroxime versus piperacillin/tazobactam.
Topics: Aged; Bacterial Infections; beta-Lactamases; Biopsy, Needle; Cefuroxime; Drug Therapy, Combination; Humans; Injections, Intravenous; Male; Penicillanic Acid; Piperacillin; Prospective Studies; Prostate; Prostatic Neoplasms; Tazobactam | 1995 |
Piperacillin/tazobactam in comparison with clindamycin plus gentamicin in the treatment of intra-abdominal infections.
Topics: Abdomen; Bacterial Infections; Clindamycin; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 1995 |
[Comprehensive evaluation of pharmacokinetic and clinical studies on tazobactam/piperacillin in pediatric field].
Topics: Adolescent; Bacteria; Bacterial Infections; Child, Preschool; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Infant; Infusions, Intravenous; Male; Penicillanic Acid; Piperacillin; Tazobactam | 1995 |
Piperacillin/tazobactam in complicated urinary tract infections.
Topics: Bacterial Infections; beta-Lactamase Inhibitors; Drug Combinations; Female; Follow-Up Studies; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Recurrence; Remission Induction; Tazobactam; Urinary Tract Infections | 1994 |
Piperacillin and tazobactam versus clindamycin and gentamicin in the treatment of hospitalized women with pelvic infection. The Piperacillin/tazobactam Study Group.
Topics: Bacterial Infections; beta-Lactamase Inhibitors; Clindamycin; Drug Administration Schedule; Drug Therapy, Combination; Endometritis; Female; Gentamicins; Humans; Pelvic Inflammatory Disease; Penicillanic Acid; Piperacillin; Tazobactam | 1994 |
Piperacillin/tazobactam versus imipenem/cilastatin in the treatment of intra-abdominal infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; beta-Lactamase Inhibitors; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Humans; Imipenem; Infusions, Intravenous; Male; Middle Aged; Penicillanic Acid; Peritoneal Diseases; Piperacillin; Tazobactam; Treatment Outcome | 1993 |
Safety profile of piperacillin/tazobactam in phase I and III clinical studies.
Topics: Bacterial Infections; beta-Lactamase Inhibitors; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Penicillanic Acid; Piperacillin; Tazobactam | 1993 |
A randomized multicenter trial of piperacillin/tazobactam versus imipenem/cilastatin in the treatment of severe intra-abdominal infections. Swedish Study Group.
Topics: Abdomen; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; beta-Lactamase Inhibitors; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Injections, Intravenous; Male; Middle Aged; Penicillanic Acid; Piperacillin; Tazobactam | 1993 |
Piperacillin/tazobactam/amikacin versus piperacillin/amikacin/teicoplanin in the empirical treatment of neutropenic patients.
Topics: Adolescent; Adult; Aged; Amikacin; Bacteremia; Bacteria; Bacterial Infections; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Prospective Studies; Tazobactam; Teicoplanin | 1993 |
Susceptibility of anaerobes in phase 3 clinical studies of piperacillin/tazobactam.
Topics: Bacteria, Anaerobic; Bacterial Infections; beta-Lactamase Inhibitors; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam | 1993 |
Prospective randomized study of piperacillin/tazobactam therapy of surgically treated intra-abdominal infection. The Piperacillin/Tazobactam Intra-Abdominal Infection Study Group.
Topics: Abdomen; Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Appendicitis; Bacterial Infections; beta-Lactamase Inhibitors; Cholangitis; Cholecystitis; Clindamycin; Combined Modality Therapy; Diverticulitis; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Prospective Studies; Tazobactam | 1993 |
Clinical pharmacokinetics of piperacillin-tazobactam combination in patients with major burns and signs of infection.
Topics: Adult; Bacterial Infections; beta-Lactamase Inhibitors; Burns; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Prospective Studies; Tazobactam | 1996 |
[Clinical study of tazobactam/piperacillin in obstetrics and gynecological infections].
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Drug Therapy, Combination; Female; Genital Diseases, Female; Humans; Infusions, Intravenous; Middle Aged; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam | 1996 |
[Use of piperacillin/tazobactam as empirical monotherapy in the treatment of bacterial infections in a resuscitation department].
Topics: Adult; Bacterial Infections; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Hospital Departments; Humans; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Resuscitation; Treatment Outcome | 1997 |
[Effect of piperacillin/tazobactam on the anti-infection resistance in patients with infections in the peritoneal cavity].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Drug Therapy, Combination; Humans; Immunity, Innate; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Peritoneal Diseases; Piperacillin; Piperacillin, Tazobactam Drug Combination | 1997 |
[Clinical studies of tazobactam/piperacillin (TAZ/PIPC) in pediatric patients].
Topics: Adolescent; Bacteria; Bacterial Infections; Child; Child, Preschool; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Injections, Intravenous; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 1998 |
[Pharmacokinetic and clinical evaluation of tazobactam/piperacillin in the pediatric field].
Topics: Bacteria; Bacterial Infections; Child; Child, Preschool; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Infant; Infusions, Intravenous; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 1998 |
[Pharmacokinetic, bacteriological and clinical evaluation of tazobactam/piperacillin in pediatrics].
Topics: Bacterial Infections; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Infusions, Intravenous; Injections, Intravenous; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 1998 |
[Laboratory and clinical studies on tazobactam/piperacillin in the field of pediatrics].
Topics: Bacterial Infections; beta-Lactamase Inhibitors; Child, Preschool; Drug Therapy, Combination; Escherichia coli; Female; Haemophilus; Haemophilus influenzae; Humans; Infant; Male; Penicillanic Acid; Penicillin Resistance; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Staphylococcus aureus; Streptococcus pneumoniae; Urinary Tract Infections | 1998 |
[Fundamental and clinical studies on tazobactam/piperacillin in the pediatric field].
Topics: Bacterial Infections; beta-Lactamase Inhibitors; Child; Drug Therapy, Combination; Female; Humans; Infant; Male; Penicillanic Acid; Pharyngitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Respiratory Tract Infections; Staphylococcus aureus; Tonsillitis; Whooping Cough | 1998 |
[Basic and clinical studies on tazobactam/piperacillin in pediatric field].
Topics: Acute Disease; Bacterial Infections; beta-Lactamase Inhibitors; Bordetella pertussis; Bronchitis; Child; Child, Preschool; Drug Therapy, Combination; Female; Haemophilus influenzae; Humans; Infant; Lymphadenitis; Male; Otitis Media, Suppurative; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Staphylococcus aureus; Streptococcus agalactiae; Streptococcus pneumoniae; Streptococcus pyogenes; Urinary Tract Infections; Whooping Cough | 1998 |
Cost-minimization analysis of piperacillin/tazobactam versus imipenem/cilastatin for the treatment of serious infections: a Canadian hospital perspective.
Topics: Adult; Anti-Infective Agents; Bacterial Infections; British Columbia; Cilastatin; Costs and Cost Analysis; Decision Trees; Double-Blind Method; Drug Therapy, Combination; Economics, Pharmaceutical; Enzyme Inhibitors; Female; Humans; Imipenem; Male; Models, Economic; Penicillanic Acid; Penicillins; Piperacillin; Prospective Studies; Protease Inhibitors; Statistics, Nonparametric; Tazobactam; Thienamycins; Treatment Outcome | 1999 |
Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin as empiric therapy for fever in severely neutropenic patients.
Topics: Adult; Anti-Bacterial Agents; Antineoplastic Agents; Bacteremia; Bacterial Infections; Case-Control Studies; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fever; Fever of Unknown Origin; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Penicillins; Piperacillin; Prospective Studies; Tazobactam; Tobramycin; Vancomycin | 1999 |
Randomized prospective study comparing cost-effectiveness of teicoplanin and vancomycin as second-line empiric therapy for infection in neutropenic patients.
Topics: Amikacin; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Blood Chemical Analysis; Cost-Benefit Analysis; Drug Costs; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Prospective Studies; Safety; Tazobactam; Teicoplanin; Treatment Failure; Vancomycin | 1999 |
Piperacillin/tazobactam compared with cefuroxime/ metronidazole in the treatment of intra-abdominal infections.
Topics: Abdominal Abscess; Appendicitis; Bacterial Infections; beta-Lactamase Inhibitors; Cefuroxime; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Intestinal Perforation; Male; Metronidazole; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Rupture, Spontaneous; Surgical Wound Infection; Tazobactam | 1999 |
Comparison of intravenous/oral ciprofloxacin plus metronidazole versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections.
Topics: Abdomen; Abdominal Abscess; Administration, Oral; Anti-Infective Agents; Appendicitis; Bacterial Infections; Ciprofloxacin; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Male; Metronidazole; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies | 2000 |
Clinafloxacin versus piperacillin-tazobactam in treatment of patients with severe skin and soft tissue infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacterial Infections; beta-Lactamase Inhibitors; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fluoroquinolones; Humans; Male; Middle Aged; Penicillanic Acid; Penicillins; Piperacillin; Skin Diseases, Infectious; Tazobactam | 2001 |
Piperacillin, beta-lactam inhibitor plus gentamicin as empirical therapy of a sequential regimen in febrile neutropenia of pediatric cancer patients.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Child; Drug Therapy, Combination; Enzyme Inhibitors; Fever; Gentamicins; Germany; Humans; Neoplasms; Neutropenia; Penicillanic Acid; Penicillins; Piperacillin; Prospective Studies; Sulbactam; Tazobactam; Treatment Outcome | 2001 |
A multicenter, double-blind, placebo-controlled trial comparing piperacillin-tazobactam with and without amikacin as empiric therapy for febrile neutropenia.
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Double-Blind Method; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Treatment Outcome | 2001 |
[Comparison of 2 administration protocols (continuous or discontinuous) of a time-dependent antibiotic, Tazocin].
Topics: Adolescent; Adult; Aged; Area Under Curve; Bacteria, Anaerobic; Bacterial Infections; Drug Administration Schedule; Drug Therapy, Combination; Enterobacteriaceae Infections; Female; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2001 |
Piperacillin/Tazobactam versus cefotaxime plus metronidazole for treatment of children with intra-abdominal infections requiring surgery.
Topics: Abdominal Abscess; Adolescent; Appendicitis; Bacterial Infections; Cefotaxime; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Intestinal Perforation; Male; Metronidazole; Microbial Sensitivity Tests; Penicillanic Acid; Peritonitis; Piperacillin; Prospective Studies; Tazobactam; Treatment Outcome | 2001 |
[Multicentre clinical trial on efficacy and safety of domestic piperacillin/tazobactam for treatment of acute bacterial infections].
Topics: Adolescent; Adult; Aged; Bacteria; Bacterial Infections; Drug Therapy, Combination; Humans; Middle Aged; Penicillanic Acid; Piperacillin; Skin Diseases; Tazobactam; Treatment Outcome | 2001 |
Clinical efficacy and pharmacoeconomics of a continuous-infusion piperacillin-tazobactam program in a large community teaching hospital.
Topics: Aged; Aged, 80 and over; Bacterial Infections; Chi-Square Distribution; Drug Therapy, Combination; Female; Hospitals, Community; Hospitals, Teaching; Humans; Infusions, Intravenous; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Statistics, Nonparametric | 2002 |
Piperacillin/tazobactam plus gentamicin as empirical therapy for febrile neutropenic patients with haematological malignancy.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bacterial Infections; beta-Lactamase Inhibitors; Bone Marrow Transplantation; Drug Therapy, Combination; Female; Fever; Gentamicins; Humans; Leukemia; Lymphoma; Male; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Tazobactam | 1992 |
Piperacillin-tazobactam versus imipenem-cilastatin for treatment of intra-abdominal infections.
Topics: Abdomen; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Tazobactam; Treatment Outcome | 1992 |
Inhibition of beta-lactamase-induced resistance in soft-tissue infections.
Topics: Abscess; Adolescent; Adult; Aged; Ampicillin; Bacteria; Bacterial Infections; beta-Lactamases; Cellulitis; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Penicillin G; Penicillin Resistance; Staphylococcal Infections; Sulbactam | 1985 |
Sulbactam/ampicillin: effects on glucose metabolism in diabetics with soft tissue infection.
Topics: Ampicillin; Bacterial Infections; Blood Glucose; C-Peptide; Diabetes Complications; Diabetes Mellitus; Drug Therapy, Combination; Floxacillin; Glucagon; Humans; Middle Aged; Penicillanic Acid; Sulbactam; Time Factors | 1985 |
Comparative clinical study of Sulbactam and ampicillin and clindamycin and tobramycin in infections of soft tissues.
Topics: Adult; Ampicillin; Bacterial Infections; beta-Lactamase Inhibitors; Cellulitis; Clindamycin; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Prospective Studies; Random Allocation; Sulbactam; Tobramycin | 1986 |
Sulbactam/ampicillin versus cefoxitin in the treatment of obstetric and gynaecological infections.
Topics: Adolescent; Adult; Ampicillin; Bacterial Infections; beta-Lactamase Inhibitors; Cefoxitin; Child; Clinical Trials as Topic; Drug Therapy, Combination; Endometritis; Female; Genital Diseases, Female; Humans; Penicillanic Acid; Peritonitis; Random Allocation; Salpingitis; Sulbactam | 1986 |
Ampicillin/sulbactam versus metronidazole-gentamicin in the treatment of soft tissue pelvic infections.
Topics: Ampicillin; Bacterial Infections; Clinical Trials as Topic; Drug Combinations; Female; Genital Diseases, Female; Gentamicins; Humans; Metronidazole; Penicillanic Acid; Prospective Studies; Random Allocation; Sulbactam | 1987 |
FL 1039 in bacteriuria following prostatectomy. A double-blind comparison with pivampicillin and placebo.
Topics: Aged; Amidines; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Bacteriuria; Clinical Trials as Topic; Drug Therapy, Combination; Enterobacteriaceae Infections; Escherichia coli Infections; Humans; Klebsiella Infections; Lactams; Male; Microbial Sensitivity Tests; Penicillanic Acid; Placebos; Postoperative Complications; Propionates; Prostatectomy; Proteus Infections; Staphylococcal Infections; Urinary Tract Infections | 1974 |
136 other study(ies) available for penicillanic acid and Bacterial Disease
| Article | Year |
|---|---|
Dose optimization of piperacillin/tazobactam in critically ill children.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Critical Illness; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infant; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Monte Carlo Method; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Tazobactam | 2017 |
Hospital Length of Stay Among Patients Receiving Intermittent Versus Prolonged Piperacillin/Tazobactam Infusion in the Intensive Care Units.
Topics: Aged; Anti-Bacterial Agents; Bacterial Infections; Critical Illness; Female; Hospital Mortality; Humans; Infusions, Intravenous; Intensive Care Units; Length of Stay; Linear Models; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies | 2018 |
Using Population Pharmacokinetic Modeling and Monte Carlo Simulations To Determine whether Standard Doses of Piperacillin in Piperacillin-Tazobactam Regimens Are Adequate for the Management of Febrile Neutropenia.
Topics: Aged; Anti-Bacterial Agents; Bacterial Infections; Creatinine; Febrile Neutropenia; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2017 |
Considerable variation of trough β-lactam concentrations in older adults hospitalized with infection-a prospective observational study.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Bacterial Infections; beta-Lactams; Cefotaxime; Drug Monitoring; Female; Humans; Length of Stay; Male; Meropenem; Patient Readmission; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Sepsis; Sweden; Thienamycins | 2018 |
Gram negative anaerobe susceptibility testing in clinical isolates using Sensititre and Etest methods.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Carbapenems; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2018 |
[Analysis of the distribution characteristics and drug resistance of non-fermenting bacterial infection in intensive care unit from 2009 to 2015]
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Cefoperazone; Cephalosporins; Cross Infection; Drug Resistance; Drug Resistance, Bacterial; Gram-Negative Bacteria; Humans; Imipenem; Intensive Care Units; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Retrospective Studies; Thienamycins | 2016 |
Novel insights into the chemistry of an old medicine: A general degradative pathway for penicillins from a piperacillin/tazobactam stability study.
Topics: Anti-Bacterial Agents; Bacterial Infections; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam | 2019 |
Reply to Soman et al and Frippiat et al.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Female; Humans; Male; Penicillanic Acid; Piperacillin; Sepsis | 2013 |
Are prolonged/continuous infusions of β-lactams for all?
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Female; Humans; Male; Penicillanic Acid; Piperacillin; Sepsis | 2013 |
Is extended or continuous infusion of carbapenems the obvious solution to improve clinical outcomes and reduce mortality?
Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Humans; Penicillanic Acid; Piperacillin | 2013 |
The Pediatric Infectious Disease Journal® newsletter.
Topics: Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Colistin; Humans; Infant; Infant, Newborn; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Public Health Administration; Virus Diseases | 2013 |
Effectiveness and safety of generic formulation of piperacillin/tazobactam (Astaz-P) for treatment of infected patients at Siriraj Hospital.
Topics: Adolescent; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Child; Drugs, Generic; Female; Hospitals; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Tazobactam; Thailand; Young Adult | 2013 |
Comparative in-vitro activity of cefoperazone-tazobactam and cefoperazone-sulbactam combinations against ESBL pathogens in respiratory and urinary infections.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Cephalosporin Resistance; Disk Diffusion Antimicrobial Tests; Drug Combinations; Humans; India; Penicillanic Acid; Respiratory Tract Infections; Sulbactam; Tazobactam; Urinary Tract Infections | 2012 |
Physical compatibility of vancomycin and piperacillin sodium-tazobactam at concentrations typically used during prolonged infusions.
Topics: Anti-Bacterial Agents; Bacterial Infections; Drug Administration Schedule; Drug Combinations; Drug Stability; Humans; Infusions, Intravenous; Isotonic Solutions; Nephelometry and Turbidimetry; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Time Factors; Vancomycin | 2013 |
Susceptibility to antibiotics of aerobic bacteria isolated from community acquired secondary peritonitis in children: therapeutic guidelines might not always fit with and everyday experience.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Child; Community-Acquired Infections; Drug Resistance, Bacterial; Drug Therapy, Combination; Ertapenem; Gentamicins; Hospitals, Pediatric; Humans; Italy; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Practice Guidelines as Topic; Sulbactam; Thienamycins | 2013 |
Population pharmacokinetics of piperacillin/tazobactam in critically ill young children.
Topics: Bacterial Infections; Child; Child, Preschool; Cohort Studies; Critical Illness; Female; Humans; Infant; Intensive Care Units, Pediatric; Male; Monte Carlo Method; Penicillanic Acid; Philadelphia; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2014 |
Interaction between caspofungin or voriconazole and cefoperazone-sulbactam or piperacillin-tazobactam by in vitro and in vivo methods.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Candida albicans; Candidiasis; Caspofungin; Cefoperazone; Drug Interactions; Echinocandins; Female; Lipopeptides; Mice; Mice, Inbred BALB C; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pyrimidines; Sulbactam; Triazoles; Voriconazole | 2014 |
Population pharmacokinetic analysis of piperacillin in burn patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Burns; Computer Simulation; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Models, Statistical; Monte Carlo Method; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Young Adult | 2014 |
Individualization of piperacillin dosing for critically ill patients: dosing software to optimize antimicrobial therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Bayes Theorem; Creatinine; Critical Illness; Drug Dosage Calculations; Drug Therapy, Computer-Assisted; Female; Humans; Male; Metabolic Clearance Rate; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Precision Medicine; Pseudomonas aeruginosa; Young Adult | 2014 |
Bacterial and fungal infections in the early post-transplantation period after liver transplantation: etiologic agents and their susceptibility.
Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antifungal Agents; Bacterial Infections; Female; Fluconazole; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Intestines; Liver Transplantation; Male; Middle Aged; Mycoses; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Postoperative Complications; Prospective Studies | 2014 |
Relevance of various animal models of human infections to establish therapeutic equivalence of a generic product of piperacillin/tazobactam.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Disease Models, Animal; Enterobacter cloacae; Humans; Mesothelin; Mice; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus; Tazobactam | 2015 |
Epidemiology of antimicrobial resistance in an oncology center in eastern India.
Topics: Acinetobacter; Amikacin; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Cancer Care Facilities; Carbapenems; Ceftazidime; Ciprofloxacin; Clindamycin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Enterobacteriaceae; Feces; Fluconazole; Gentamicins; Humans; India; Methicillin-Resistant Staphylococcus aureus; Mycoses; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas; Yeasts | 2015 |
Top Guns: The "Maverick" and "Goose" of Empiric Therapy.
Topics: Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Bacterial Infections; Critical Illness; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Renal Insufficiency; Retrospective Studies; Risk Assessment; Vancomycin | 2016 |
Noninferiority Doesn't Mean Not Inferior.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Drug Resistance, Multiple, Bacterial; Female; Humans; Intraabdominal Infections; Male; Metronidazole; Penicillanic Acid | 2016 |
Response to Spellberg and Brass.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Drug Resistance, Multiple, Bacterial; Female; Humans; Intraabdominal Infections; Male; Metronidazole; Penicillanic Acid | 2016 |
Pharmacokinetics and Pharmacodynamics of Extended Infusion Versus Short Infusion Piperacillin-Tazobactam in Critically Ill Patients Undergoing CRRT.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Critical Illness; Dialysis Solutions; Female; Hemodiafiltration; Humans; Infusions, Intravenous; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Time Factors | 2016 |
Piperacillin-Tazobactam-induced Adverse Drug Events in Pediatric Patients on Outpatient Parenteral Antimicrobial Therapy.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Female; Humans; Infant; Infusions, Parenteral; Kaplan-Meier Estimate; Male; Outpatients; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2017 |
Newer Intravenous Antibiotics in the Intensive Care Unit: Ceftaroline, Ceftolozane-Tazobactam, and Ceftazidime-Avibactam.
Topics: Administration, Intravenous; Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Infections; Ceftazidime; Cephalosporins; Drug Combinations; Education, Medical, Continuing; Humans; Intensive Care Units; Penicillanic Acid; Tazobactam; United States | 2016 |
[Clinical analysis for patients with continuous ambulatory peritoneal dialysis associated peritonitis].
Topics: Abdominal Pain; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Candidiasis; Catheters; Diarrhea; Drug Resistance, Bacterial; Enterococcus faecalis; Escherichia coli; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mycoses; Penicillanic Acid; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Recurrence; Retrospective Studies; Staphylococcus epidermidis; Staphylococcus haemolyticus; Vomiting | 2016 |
Piperacillin-tazobactam penetration into human pancreatic juice.
Topics: Aged; Ampulla of Vater; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Common Bile Duct Neoplasms; Female; Humans; Male; Middle Aged; Pancreatic Diseases; Pancreatic Juice; Pancreatic Neoplasms; Pancreaticoduodenectomy; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2008 |
Foot infections in diabetes (DFIs) in the out-patient setting: an Italian multicentre observational survey.
Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care; Anti-Bacterial Agents; Bacterial Infections; Diabetic Foot; Female; Humans; Italy; Male; Middle Aged; Outpatient Clinics, Hospital; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas Infections; Staphylococcal Infections; Young Adult | 2008 |
Pylephlebitis after a duodenal ulcer in a patient with metastasised colon carcinoma treated with chemotherapy and bevacizumab: a case report.
Topics: Aged; Amoxicillin; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bacterial Infections; Bevacizumab; Clavulanic Acid; Colorectal Neoplasms; Duodenal Ulcer; Humans; Male; Penicillanic Acid; Piperacillin; Portal Vein; Tazobactam; Thrombophlebitis | 2009 |
Accounting for the development of antibacterial resistance in the cost effectiveness of ertapenem versus piperacillin/tazobactam in the treatment of diabetic foot infections in the UK.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cost-Benefit Analysis; Decision Trees; Diabetic Foot; Direct Service Costs; Drug Costs; Drug Resistance, Bacterial; Ertapenem; Humans; Models, Biological; Models, Econometric; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Quality-Adjusted Life Years; Treatment Outcome; United Kingdom | 2009 |
Daily serum piperacillin monitoring is advisable in critically ill patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Critical Illness; Drug Monitoring; Female; France; Hospitals, Teaching; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Penicillanic Acid; Piperacillin; Prospective Studies; Serum; Tazobactam; Time Factors | 2010 |
Antithymocyte globulin-induced acute lung injury during transplantation for aplastic anemia.
Topics: Acute Lung Injury; Anemia, Aplastic; Animals; Anti-Bacterial Agents; Antilymphocyte Serum; Bacterial Infections; Bone Marrow Transplantation; Child; Cyclophosphamide; Horses; Humans; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Transplantation Conditioning; Vancomycin; Vidarabine | 2011 |
Analysis of isolated bacteria and short-term antimicrobial prophylaxis with tazobactam-piperacillin (1:4 ratio) for prevention of postoperative infections after radical cystectomy.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteria; Bacterial Infections; Cystectomy; Female; Humans; Japan; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Surgical Wound Infection; Treatment Outcome; Urinary Tract Infections | 2012 |
Dosing of piperacillin/tazobactam in a morbidly obese patient.
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Chromatography, High Pressure Liquid; Drug Monitoring; Humans; Male; Obesity; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Serum | 2012 |
Microbiological and clinical characteristics of diabetic foot infections in northern India.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Diabetic Foot; Female; Humans; India; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prevalence; Prospective Studies | 2012 |
Characteristics of initial compared with subsequent bacterial infections among hospitalised haemato-oncological patients.
Topics: Adult; Aged; Aged, 80 and over; Bacteremia; Bacterial Infections; Ceftazidime; Drug Resistance, Bacterial; Escherichia coli; Fever; Gram-Positive Bacteria; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Hospitalization; Humans; Israel; Meropenem; Middle Aged; Odds Ratio; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Thienamycins; Treatment Outcome; Young Adult | 2012 |
[Inhibitors of the New Delhi-Metallolactamase].
Topics: Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactamases; Cell Membrane; Clavulanic Acid; Drug Resistance, Bacterial; Drug Resistance, Microbial; Enzyme Inhibitors; Klebsiella pneumoniae; Methicillin-Resistant Staphylococcus aureus; Penicillanic Acid; Tazobactam | 2012 |
Case-control study of drug monitoring of β-lactams in obese critically ill patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Case-Control Studies; Cefepime; Ceftazidime; Cephalosporins; Drug Monitoring; Enzyme Inhibitors; Female; Humans; Male; Meropenem; Middle Aged; Obesity; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Renal Replacement Therapy; Sepsis; Shock, Septic; Tazobactam; Thienamycins; Young Adult | 2013 |
Efficacy and tolerability of prophylactic treatment with intravenous piperacillin/tazobactam in patients undergoing hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Antibiotic Prophylaxis; Bacterial Infections; Drug Therapy, Combination; Female; Hematopoietic Stem Cell Transplantation; Humans; Injections, Intravenous; Male; Middle Aged; Mycoses; Penicillanic Acid; Pilot Projects; Piperacillin; Tazobactam; Transplantation, Autologous; Transplantation, Homologous | 2002 |
In vitro activity of ertapenem against common clinical isolates in relation to human pharmacokinetics.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Ceftriaxone; Community-Acquired Infections; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae; Ertapenem; Haemophilus influenzae; Humans; Lactams; Microbial Sensitivity Tests; Moraxella catarrhalis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Staphylococcus aureus; Streptococcus agalactiae; Streptococcus pyogenes | 2002 |
[Outpatient parenteral antibiotic therapy (OPAT) of diabetic foot infections with piperacillin/tazobactam].
Topics: Adult; Aged; Ambulatory Care; Anti-Bacterial Agents; Bacterial Infections; Diabetic Foot; Female; Humans; Injections; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies | 2002 |
In vitro activity of piperacillin/tazobactam and other broad-spectrum antibiotics against bacteria from hospitalised patients in the British Isles.
Topics: Bacteria; Bacterial Infections; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Enterobacteriaceae; Gram-Negative Bacteria; Humans; In Vitro Techniques; Ireland; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Time Factors; United Kingdom | 2003 |
Piperacillin/tazobactam-induced acute delirium in a peritoneal dialysis patient.
Topics: Anti-Bacterial Agents; Bacterial Infections; Confusion; Delirium; Drug Therapy, Combination; Gram-Positive Bacterial Infections; Hallucinations; Humans; Kidney Failure, Chronic; Male; Middle Aged; Penicillanic Acid; Peritoneal Dialysis, Continuous Ambulatory; Piperacillin; Tazobactam | 2004 |
[Treatment mostly not in line with current knowledge. New guidelines for sinusitis therapy].
Topics: Acute Disease; Bacterial Infections; Ceftibuten; Cephalosporins; Chronic Disease; Clavulanic Acid; Drug Resistance, Multiple; Humans; Mometasone Furoate; Penicillanic Acid; Pregnadienediols; Sinusitis; Treatment Outcome | 2004 |
Antimicrobial susceptibility of aerobic microorganisms isolated from intraabdominal infections in pediatric patients in Poland.
Topics: Abdomen; Adolescent; Bacteria, Aerobic; Bacterial Infections; beta-Lactamases; Child; Child, Preschool; Drug Resistance, Bacterial; Enterobacteriaceae; Escherichia coli; Humans; Infant; Infant, Newborn; Klebsiella; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Poland; Pseudomonas aeruginosa | 2005 |
Comparative in vitro antimicrobial activity of a novel quinolone, garenoxacin, against aerobic and anaerobic microbial isolates recovered from general, vascular, cardiothoracic and otolaryngologic surgical patients.
Topics: Anti-Bacterial Agents; Aza Compounds; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; Fluoroquinolones; Humans; Imipenem; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Quinolines | 2005 |
Synergistic activity of piperacillin: YTR-830H combinations in vitro and in vivo.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Gastric Juice; Hydrogen-Ion Concentration; Mice; Microbial Sensitivity Tests; Mucins; Penicillanic Acid; Piperacillin; Swine; Tazobactam | 1989 |
Pharmacodynamic modeling of imipenem-cilastatin, meropenem, and piperacillin-tazobactam for empiric therapy of skin and soft tissue infections: a report from the OPTAMA Program.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Dose-Response Relationship, Drug; Drug Combinations; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Models, Biological; Monte Carlo Method; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Population Surveillance; Prevalence; Soft Tissue Infections; Thienamycins | 2005 |
In-vitro evaluation of "piperacillin and tazobactum" combination in a tertiary-care hospital--a preliminary study.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Hospitals; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam | 2006 |
Clinical correlation of the CLSI susceptibility breakpoint for piperacillin- tazobactam against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella species.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Escherichia coli; Female; Humans; Klebsiella oxytoca; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Time Factors; Treatment Outcome; Urinary Tract Infections | 2006 |
Kinetics of galactomannan in surgical patients receiving perioperative piperacillin/tazobactam prophylaxis.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Colon; False Positive Reactions; Female; Galactose; Gastrectomy; Humans; Kinetics; Male; Mannans; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Rectum | 2006 |
Influence of culture site-specific MIC distributions on the pharmacokinetic and pharmacodynamic properties of piperacillin/tazobactam and piperacillin: a data analysis.
Topics: Anti-Bacterial Agents; Bacterial Infections; Data Interpretation, Statistical; Enzyme Inhibitors; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Monte Carlo Method; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam | 2006 |
Bactericidal activity of ertapenem against major intra-abdominal pathogens.
Topics: Abdomen; Anti-Bacterial Agents; Bacterial Infections; Bacteroides fragilis; beta-Lactams; Ceftazidime; Ceftriaxone; Digestive System Diseases; Enterobacter cloacae; Enterococcus faecalis; Ertapenem; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Klebsiella; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Proteus mirabilis; Staphylococcus aureus; Time Factors | 2006 |
Restricted use of glycopeptides in paediatric cancer patients with fever and neutropenia.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever; Fever of Unknown Origin; Fosfomycin; Glycopeptides; Humans; Infant; Length of Stay; Male; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Teicoplanin; Treatment Outcome | 2006 |
Experience with the use of piperacillin-tazobactam in pediatric non-renal solid organ transplantation.
Topics: Adolescent; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Child; Child, Preschool; Drug Therapy, Combination; Humans; Infant; Mycoses; Organ Transplantation; Penicillanic Acid; Piperacillin; Tazobactam | 2007 |
Clinical predictors of treatment failure for diabetic foot infections: data from a prospective trial.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Diabetic Foot; Ertapenem; Female; Humans; Leukocyte Count; Male; Middle Aged; Multivariate Analysis; Outcome Assessment, Health Care; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Severity of Illness Index; Treatment Failure | 2007 |
Consensus statement on antimicrobial therapy of intra-abdominal infections in Asia.
Topics: Abdomen; Anti-Infective Agents; Asia; Bacterial Infections; beta-Lactamase Inhibitors; Consensus; Drug Resistance, Bacterial; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Fluoroquinolones; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Practice Guidelines as Topic | 2007 |
Comparative costs of ertapenem and piperacillin-tazobactam in the treatment of diabetic foot infections.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Diabetic Foot; Drug Administration Schedule; Drug Combinations; Ertapenem; Female; Health Care Costs; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2007 |
Inadequate antimicrobial prophylaxis during surgery: a study of beta-lactam levels during burn debridement.
Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; beta-Lactams; Burns; Cephalothin; Debridement; Drug Administration Schedule; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus; Tazobactam | 2007 |
Piperacillin-tazobactam in pediatric cancer patients younger than 25 months: a retrospective multicenter survey.
Topics: Bacterial Infections; Fever of Unknown Origin; Humans; Hypersensitivity; Infant; Infant, Newborn; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Treatment Outcome; Withholding Treatment | 2007 |
Amdinocillin.
Topics: Amdinocillin; Bacterial Infections; Enterobacteriaceae; Humans; Penicillanic Acid | 1984 |
[Clinical studies on sulbactam/cefoperazone in pediatric field].
Topics: Age Factors; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Child, Preschool; Drug Combinations; Drug Evaluation; Female; Humans; Infant; Infusions, Parenteral; Injections, Intravenous; Male; Penicillanic Acid; Sulbactam | 1984 |
[Clinical experience on sulbactam/cefoperazone in the pediatric field].
Topics: Adolescent; Age Factors; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Child; Child, Preschool; Drug Combinations; Drug Evaluation; Female; Humans; Infant; Injections, Intravenous; Male; Penicillanic Acid; Respiratory Tract Infections; Sulbactam | 1984 |
[Clinical studies of sulbactam/cefoperazone therapy in pediatric bacterial infections].
Topics: Age Factors; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Child; Child, Preschool; Drug Combinations; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Infant; Injections, Intravenous; Male; Penicillanic Acid; Sulbactam | 1984 |
[Clinical studies on sulbactam/cefoperazone in the pediatric field].
Topics: Age Factors; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Child; Child, Preschool; Drug Combinations; Drug Evaluation; Female; Humans; Infant; Injections, Intravenous; Male; Penicillanic Acid; Sulbactam | 1984 |
[Clinical evaluation of sulbactam/cefoperazone in the pediatric infections].
Topics: Adolescent; Age Factors; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Child; Child, Preschool; Drug Combinations; Drug Evaluation; Female; Humans; Infant; Male; Penicillanic Acid; Sulbactam | 1984 |
[Fundamental and clinical studies of sulbactam/cefoperazone in the pediatric field].
Topics: Age Factors; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Child; Child, Preschool; Drug Combinations; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Infant; Male; Penicillanic Acid; Sulbactam | 1984 |
[Experimental and clinical studies of sulbactam/cefoperazone in pediatric field].
Topics: Adolescent; Age Factors; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Child; Child, Preschool; Drug Combinations; Drug Evaluation; Drug Resistance, Microbial; Female; Half-Life; Humans; Infant; Male; Penicillanic Acid; Sulbactam | 1984 |
[Studies on sulbactam/cefoperazone in the field of pediatrics].
Topics: Acute Disease; Adolescent; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Child; Child, Preschool; Drug Combinations; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Infant; Male; Penicillanic Acid; Sulbactam | 1984 |
[Laboratory and clinical studies of sulbactam/cefoperazone in the pediatric field].
Topics: Adolescent; Age Factors; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Child; Child, Preschool; Drug Combinations; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Kinetics; Male; Penicillanic Acid; Sulbactam | 1984 |
[Basic and clinical studies of sulbactam/cefoperazone in pediatric field].
Topics: Abscess; Adolescent; Age Factors; Animals; Bacterial Infections; beta-Lactamase Inhibitors; Blepharitis; Cefoperazone; Drug Combinations; Female; Humans; Meningitis; Penicillanic Acid; Rabbits; Staphylococcal Infections; Sulbactam | 1984 |
[Clinical and bacteriological efficiency of sulbactam/cefoperazone in gynecological infectious diseases].
Topics: Adult; Aged; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Drug Combinations; Drug Evaluation; Female; Genital Diseases, Female; Humans; Infusions, Parenteral; Middle Aged; Penicillanic Acid; Pregnancy; Sulbactam | 1984 |
[Clinical evaluation of sulbactam/cefoperazone in obstetric and gynecological infection].
Topics: Adult; Aged; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Drug Combinations; Drug Evaluation; Female; Genital Diseases, Female; Humans; Infusions, Parenteral; Middle Aged; Penicillanic Acid; Pregnancy; Pregnancy Complications, Infectious; Sulbactam | 1984 |
[Clinical evaluation of sulbactam/cefoperazone for infections in the field of obstetrics and gynecology].
Topics: Abortion, Induced; Adult; Aged; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Drug Combinations; Drug Evaluation; Female; Genital Diseases, Female; Humans; Infusions, Parenteral; Middle Aged; Penicillanic Acid; Postoperative Complications; Pregnancy; Sulbactam | 1984 |
[Experience with sulbactam/cefoperazone in the field of obstetrics and gynecology].
Topics: Adolescent; Adult; Aged; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Drug Combinations; Drug Evaluation; Female; Genital Diseases, Female; Humans; Penicillanic Acid; Sulbactam | 1984 |
[Fundamental and clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology].
Topics: Adult; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Drug Combinations; Drug Evaluation; Exudates and Transudates; Female; Genital Diseases, Female; Genitalia, Female; Humans; Middle Aged; Penicillanic Acid; Sulbactam; Tissue Distribution | 1984 |
[Clinical trial of sulbactam/cefoperazone in the field of obstetrics and gynecology].
Topics: Adult; Aged; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Drug Combinations; Drug Evaluation; Female; Genital Diseases, Female; Humans; Middle Aged; Penicillanic Acid; Sulbactam | 1984 |
[Clinical evaluation of sulbactam/cefoperazone in the field of obstetrics and gynecology].
Topics: Adolescent; Adult; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Drug Combinations; Drug Evaluation; Female; Genital Diseases, Female; Humans; Middle Aged; Penicillanic Acid; Sulbactam | 1984 |
[Clinical studies of sulbactam/cefoperazone in the field of obstetrics and gynecology].
Topics: Adult; Aged; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Drug Combinations; Drug Evaluation; Female; Genital Diseases, Female; Humans; Middle Aged; Penicillanic Acid; Sulbactam | 1984 |
[Fundamental and clinical studies of sulbactam/cefoperazone in the field of pediatrics].
Topics: Adolescent; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Child; Child, Preschool; Drug Combinations; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Injections, Intravenous; Male; Penicillanic Acid; Sulbactam | 1984 |
[Clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology].
Topics: Adult; Aged; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Drug Combinations; Drug Evaluation; Female; Genital Diseases, Female; Humans; Injections, Intravenous; Penicillanic Acid; Pregnancy; Sulbactam | 1984 |
[Fundamental and clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology].
Topics: Adult; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Drug Combinations; Drug Evaluation; Exudates and Transudates; Female; Genital Diseases, Female; Humans; Injections, Intravenous; Kinetics; Models, Biological; Pelvis; Penicillanic Acid; Pregnancy; Sulbactam | 1984 |
[Clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology].
Topics: Adult; Aged; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Drug Combinations; Drug Evaluation; Female; Genital Diseases, Female; Humans; Injections, Intravenous; Penicillanic Acid; Pregnancy; Sulbactam | 1984 |
[Clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology].
Topics: Adult; Aged; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Drug Combinations; Drug Evaluation; Female; Genital Diseases, Female; Humans; Infusions, Parenteral; Middle Aged; Penicillanic Acid; Pregnancy; Sulbactam | 1984 |
[Fundamental and clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology].
Topics: Adult; Aged; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Drug Combinations; Drug Evaluation; Female; Genital Diseases, Female; Genitalia, Female; Humans; Injections, Intravenous; Middle Aged; Penicillanic Acid; Sulbactam | 1984 |
[Fundamental and clinical studies of sulbactam/cefoperazone in obstetrics and gynecology].
Topics: Adolescent; Adult; Aged; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Drug Combinations; Drug Evaluation; Female; Genital Diseases, Female; Humans; Injections, Intravenous; Middle Aged; Penicillanic Acid; Pregnancy; Sulbactam | 1984 |
[Fundamental and clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology].
Topics: Adult; Aged; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Drug Combinations; Drug Evaluation; Exudates and Transudates; Female; Genital Diseases, Female; Genitalia, Female; Humans; Injections, Intravenous; Middle Aged; Pelvis; Penicillanic Acid; Sulbactam | 1984 |
[Clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology].
Topics: Adult; Aged; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Drug Combinations; Drug Evaluation; Female; Genital Diseases, Female; Humans; Injections, Intravenous; Middle Aged; Penicillanic Acid; Pregnancy; Sulbactam | 1984 |
[Clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology].
Topics: Adolescent; Adult; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Drug Combinations; Drug Evaluation; Female; Genital Diseases, Female; Humans; Infusions, Parenteral; Middle Aged; Penicillanic Acid; Pregnancy; Sulbactam | 1984 |
[Bacteriological, pharmacokinetic and clinical studies on sulbactam/cefoperazone in the pediatric field].
Topics: Adolescent; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Child; Child, Preschool; Drug Combinations; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Infant; Male; Penicillanic Acid; Sulbactam | 1984 |
[Basic and clinical evaluation of sulbactam/cefoperazone in the field of pediatrics].
Topics: Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Child; Child, Preschool; Drug Combinations; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Infant; Male; Penicillanic Acid; Sulbactam | 1984 |
[Clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology].
Topics: Adult; Aged; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Drug Combinations; Drug Evaluation; Drug Resistance, Microbial; Female; Genital Diseases, Female; Humans; Middle Aged; Penicillanic Acid; Sulbactam | 1984 |
Effects of ampicillin plus sulbactam on bowel flora in patients undergoing colorectal surgery.
Topics: Aged; Ampicillin; Bacterial Infections; Colon; Drug Therapy, Combination; Enterobacteriaceae; Feces; Female; Humans; Intestinal Mucosa; Male; Middle Aged; Penicillanic Acid; Postoperative Complications; Rectum; Sulbactam | 1982 |
[Amidinopenicillins (mecillinam and pivmecillinam). A new group of beta-lactamate antibiotics].
Topics: Amdinocillin; Amdinocillin Pivoxil; Bacterial Infections; Drug Evaluation; Humans; Penicillanic Acid | 1980 |
Sensitivities of clinically significant organisms to four cephalosporins, ampicillin and mecillinam.
Topics: Amdinocillin; Ampicillin; Bacterial Infections; Cefamandole; Cefoxitin; Cefuroxime; Cephalexin; Cephalosporins; Humans; Microbial Sensitivity Tests; Penicillanic Acid | 1980 |
[Effectiveness of pivmecillinam in biliary tract infection. Especially on comparison in pivmecillinam and ampicillin (author's transl)].
Topics: Adult; Aged; Amdinocillin Pivoxil; Ampicillin; Bacteria; Bacterial Infections; Bile; Biliary Tract Diseases; Drug Evaluation; Female; Humans; Male; Middle Aged; Penicillanic Acid; Penicillin Resistance | 1981 |
Effect of combination of cefsulodin and mecillinam.
Topics: Amdinocillin; Animals; Bacteria; Bacterial Infections; Cefsulodin; Cephalosporins; Drug Synergism; Drug Therapy, Combination; Male; Mice; Penicillanic Acid; Serratia marcescens; Species Specificity | 1981 |
Synergistic effect of cephalexin with mecillinam.
Topics: Amdinocillin; Animals; Bacteria; Bacterial Infections; Cephalexin; Drug Synergism; Drug Therapy, Combination; Escherichia coli; Male; Mice; Penicillanic Acid; Species Specificity | 1981 |
Treatment of infections caused by ampicillin-resistant pathogens with a combination of ampicillin and CP-45,899.
Topics: Adolescent; Adult; Aged; Ampicillin; Bacterial Infections; beta-Lactamase Inhibitors; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Penicillanic Acid; Penicillin Resistance; Sulbactam | 1982 |
[Microbiological evaluation of the results of penicillin Hx treatment of urinary tract infection].
Topics: Amdinocillin; Bacterial Infections; Bacteriuria; Candida; Candidiasis; Enterobacteriaceae; Female; Humans; Male; Micrococcus; Penicillanic Acid; Pseudomonas; Staphylococcus aureus; Streptococcus agalactiae | 1982 |
6-Acetylmethylenepenicillanic acid (Ro 15-1903), a potent beta-lactamase inhibitor. II. Antibacterial properties.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Drug Synergism; Escherichia coli; Mice; Penicillanic Acid; Pseudomonas aeruginosa | 1982 |
Amdinocillin: use alone or in combination with cefoxitin or carbenicillin-ticarcillin.
Topics: Acute Disease; Adolescent; Adult; Aged; Amdinocillin; Bacterial Infections; Carbenicillin; Cefoxitin; Drug Therapy, Combination; Female; Humans; Leukemia; Leukocyte Count; Male; Middle Aged; Neutrophils; Penicillanic Acid; Penicillins; Sepsis; Ticarcillin | 1983 |
Efficacy, pharmacology, and safety of amdinocillin in treatment of neonates.
Topics: Amdinocillin; Bacterial Infections; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Infant, Newborn, Diseases; Injections, Intramuscular; Kinetics; Male; Penicillanic Acid; Penicillins | 1983 |
Enhanced activity of beta-lactam antibiotics with amdinocillin in vitro and and in vivo.
Topics: Amdinocillin; Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Drug Synergism; Drug Therapy, Combination; Mice; Microbial Sensitivity Tests; Penicillanic Acid | 1983 |
Systemic infections treated with amdinocillin in combination with other beta-lactam antibiotics.
Topics: Amdinocillin; Anti-Bacterial Agents; Bacterial Infections; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Penicillanic Acid; Urinary Tract Infections | 1983 |
Concentrations of ampicillin plus sulbactam in serum and intestinal mucosa and effects on the colonic microflora in patients undergoing colorectal surgery.
Topics: Aged; Ampicillin; Bacterial Infections; Colon; Feces; Female; Humans; Intestinal Mucosa; Male; Middle Aged; Mycoses; Penicillanic Acid; Postoperative Complications; Rectum; Sulbactam | 1983 |
Efficacy of piperacillin/tazobactam in the treatment of experimental intra-abdominal infections.
Topics: Abdomen; Animals; Bacterial Infections; beta-Lactamase Inhibitors; Clindamycin; Drug Therapy, Combination; Gentamicins; Imipenem; Male; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Rats; Rats, Sprague-Dawley; Tazobactam | 1994 |
[Drugs: piperacillin/tazobactam].
Topics: Bacterial Infections; beta-Lactamase Inhibitors; Drug Combinations; Humans; Penicillanic Acid; Piperacillin; Tazobactam | 1995 |
The activity of piperacillin/tazobactam against clinical isolates collected in 20 UK centres and the design of a disc test for susceptibility testing.
Topics: Bacteria, Aerobic; Bacterial Infections; beta-Lactamase Inhibitors; Culture Media; Diffusion; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam; United Kingdom | 1993 |
Piperacillin/tazobactam.
Topics: Bacterial Infections; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 1994 |
Therapy of soft tissue infections with piperacillin/tazobactam.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Risk Factors; Skin Diseases, Infectious; Tazobactam | 1993 |
Susceptibility survey of piperacillin alone and in the presence of tazobactam.
Topics: Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Drug Resistance, Microbial; Drug Therapy, Combination; Gram-Negative Bacteria; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam | 1993 |
Comparative activities of novel beta-lactamase inhibitors, 6-exomethylene penamsulfones (CH1240, CH2140) in experimental mouse infection model.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Citrobacter; Clavulanic Acid; Enterobacteriaceae Infections; Enzyme Inhibitors; Escherichia coli Infections; Lethal Dose 50; Male; Mice; Mice, Inbred ICR; Penicillanic Acid; Pseudomonas Infections; Sulbactam; Triazoles | 1998 |
In vitro antimicrobial activity of piperacillin/tazobactam in comparison with other broad-spectrum beta-lactams.
Topics: Bacteria; Bacterial Infections; beta-Lactams; Brazil; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Hospitals, University; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2000 |
Cost efficacy of tazobactam/piperacillin versus imipenem/cilastatin in the treatment of intra-abdominal infection.
Topics: Abdomen; Adult; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Cost-Benefit Analysis; Decision Trees; Drug Combinations; Drug Costs; Drug Therapy, Combination; Health Care Costs; Humans; Imipenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Protease Inhibitors; Randomized Controlled Trials as Topic; Retrospective Studies; Thienamycins | 2001 |
The newer penicillins.
Topics: Ampicillin; Bacteria; Bacterial Infections; Carbenicillin; Cloxacillin; Humans; Methicillin; Nafcillin; Oxacillin; Penicillanic Acid; Penicillin G; Penicillin V; Penicillins | 1975 |
In vivo synergy between 6 beta-amidinopenicillanic acid derivatives and other antibiotics.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Drug Synergism; Mice; Penicillanic Acid | 1976 |
Synergy and mecillinam.
Topics: Amdinocillin; Ampicillin; Bacteria; Bacterial Infections; Bronchitis; Drug Synergism; Humans; Microbial Sensitivity Tests; Penicillanic Acid | 1977 |
[Pivmecillinam (Selexid)].
Topics: Amdinocillin Pivoxil; Bacterial Infections; Chemical Phenomena; Chemistry; Humans; Penicillanic Acid; Urinary Tract Infections | 1978 |
Preliminary experience with parenteral mecillinam.
Topics: Adolescent; Adult; Aged; Amdinocillin; Bacterial Infections; Female; Humans; Injections, Intramuscular; Injections, Intravenous; Male; Middle Aged; Penicillanic Acid | 1979 |
Pirbenicillin, a new semisynthetic penicillin with broad-spectrum activity.
Topics: Bacteria; Bacterial Infections; Carbenicillin; Culture Media; Escherichia coli; Guanidines; Penicillanic Acid; Penicillins; Pseudomonas aeruginosa; Pyridines; Ticarcillin | 1976 |
Conversion of benzylpenicillin to penicilloic acid in patients with chronic bronchial infections.
Topics: Administration, Oral; Adult; Bacterial Infections; Bronchitis; Carboxylic Acids; Chronic Disease; Colorimetry; Enterobacteriaceae; Humans; Injections, Intramuscular; Male; Middle Aged; Penicillanic Acid; Penicillin G; Penicillinase; Sputum; Thiazoles | 1976 |
Effect of pH on antibiotics used to treat anaerobic infection.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Cefoxitin; Clindamycin; Drug Therapy, Combination; Hydrogen-Ion Concentration; Imipenem; Metronidazole; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam | 1992 |
Effect of piperacillin/tazobactam therapy on intestinal microflora.
Topics: Adult; Aged; Aged, 80 and over; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Drug Combinations; Feces; Female; Humans; Intestines; Male; Middle Aged; Penicillanic Acid; Piperacillin; Tazobactam; Yeasts | 1992 |
Piperacillin/tazobactam in the treatment of serious acute soft tissue infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; beta-Lactamase Inhibitors; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Tazobactam | 1991 |
Comparative in vitro and in vivo activities of piperacillin combined with the beta-lactamase inhibitors tazobactam, clavulanic acid, and sulbactam.
Topics: Animals; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Female; Mice; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Sulbactam; Tazobactam | 1989 |
beta-Lactamase inhibitors.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bacterial Infections; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Humans; Penicillanic Acid; Sulbactam | 1985 |
[Passage into the human milk and clinical evaluation of sulbactam/cefoperazone].
Topics: Adolescent; Adult; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Drug Combinations; Drug Evaluation; Female; Genital Diseases, Female; Humans; Infusions, Parenteral; Injections, Intravenous; Milk, Human; Penicillanic Acid; Pregnancy; Sulbactam | 1985 |
In vitro antimicrobial activity of cefoperazone-sulbactam combinations against 554 clinical isolates including a review and beta-lactamase studies.
Topics: Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactamases; Cefoperazone; Cephalosporins; Drug Combinations; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam | 1985 |
A non-comparative study of parenteral ampicillin and sulbactam in intra-thoracic and intra-abdominal infections.
Topics: Abdomen; Adult; Aged; Ampicillin; Bacteria; Bacterial Infections; beta-Lactamases; Female; Humans; Male; Middle Aged; Penicillanic Acid; Penicillin Resistance; Respiratory Tract Infections; Sepsis; Sulbactam; Time Factors | 1986 |
Synergy of amoxycillin combined with clavulanate and YTR 830 in experimental infections in mice.
Topics: Amoxicillin; Animals; Bacterial Infections; Citrobacter; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Enterobacteriaceae Infections; Female; Mice; Penicillanic Acid; Proteus Infections; Staphylococcal Infections; Tazobactam | 1986 |
Clinical efficacy and safety of sulbactam/ampicillin in patients suffering from chronic liver disease.
Topics: Adult; Aged; Aged, 80 and over; Ampicillin; Bacterial Infections; beta-Lactamase Inhibitors; Chronic Disease; Drug Combinations; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Liver Diseases; Liver Function Tests; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Sulbactam | 1987 |
Ampicillin/sulbactam (Unasyn).
Topics: Ampicillin; Bacterial Infections; beta-Lactamase Inhibitors; Drug Combinations; Humans; Kinetics; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam | 1987 |